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1.1 Genes, gene expression, and transcriptomics
A cell is the basic structural and biological unit of life. Its structure, function, and how it
interacts  with  its  environment  are dictated  by  its  genetic  material,  which  consists  of
deoxyribonucleic acid (DNA). The smallest functional unit of DNA is defined as a gene1.
This  definition  only  included  protein-coding  regions,  a  DNA segment  transcribed  into
messenger  RNA  (mRNA)  and  translated  into  protein  via  the  ribosome.  Today,  the
characterization of a gene is more complex and encompassing. It includes all transcribed
RNA with any function or observable trait  (phenotype). Examples of non-protein-coding
(non-coding) RNA include regulatory RNA (lncRNA, miRNA), structural RNA (ribozymes
and ribosomal RNA), and transport RNA (tRNA). The sum-total of all the RNA in a cell or a
population of cells is called the transcriptome2–4. 
The central dogma in biology defines the directionality of information flow, from DNA to
RNA to protein5.  Multicellular organisms (where all  cells contain the same set of DNA)
therefore require complex regulation at each step of this central dogma to produce a wide
variety of cells with distinct functions. This varied regulation begins with RNA transcription,
also termed gene expression. Gene expression is regulated on many levels, starting with
how the cell packages its DNA in the nucleus (eukaryotic cells), also called chromatin.
Gene expression can also be affected by modifications to the DNA (methylation) and by
other  expressed  genes  (transcription  factors)  as  well  as  specific  sequences  of  DNA
preceding and sometimes following a gene (enhancers)6. In order to understand how cells
function and differ from each other, there is no better place to start than to look for a way to
measure gene expression.
Several  crucial  discoveries and technological  advances were necessary to make gene
expression (transcriptomics)  analysis a  routine laboratory method (Fig.1.1 A).  Arguably
one of the most important breakthroughs for the field of RNA research happened in 1970
when  two  scientists  independently  reported  the  discovery  of  an  enzyme  that  can
synthesize  DNA from RNA –  a  reverse  transcriptase7.  Its  name was  derived  from its
function and it opened up a whole avenue of research by allowing RNA to be transcribed
into complementary DNA (cDNA), which is more stable than the original RNA and can be
used with DNA-specific methods such as restriction digest. If synthesized from eukaryotic
mRNA, cDNA will  also not contain any introns, allowing the study and use of only the
protein-coding sequences of DNA. The first laboratory method to measure or quantify RNA
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in any meaningful way in regards to gene expression was developed by Alwine et al. In
1977,  they  showed that  it  is  possible  to  separate  the  total  RNA of  a  sample  by  gel
electrophoresis  then transfer it to a specially modified paper, hybridized the sample  to a
radioactively tagged cDNA or RNA probe and develop it. This method allows the detection
of a specific RNA in a given sample8. Initially, as mentioned, all probes were radioactively
labeled,  but  new  methods  became  available  over  time,  such  as  chemiluminescent,
fluorescent,  or  even  antibody-tagged  (immuno-Northern  blots)  probes9,10.  This  novel
method allowed accurate detection and quantification of any RNA with a known sequence.
Northern blotting  is still  in use today due to  the  accuracy and sensitivity, and ability to
directly detect RNA (Fig.1.1 B). The limitations of this method are its low throughput and
the  requirement to  know the  sequence of  the  RNA transcript  of  interest. Additionally,
quantification is relative to either a control RNA or another sample which can be error-
prone.
The next giant leap in our ability to detect and measure RNA transcripts came from the
development of  one of molecular biology’s most common technique – the Polymerase
Chain Reaction or PCR. 
Figure 1.1 (A) Major developments in gene expression analysis
In 1986, Mullis et al. developed a method that allowed them to amplify any known DNA
sequence  exponentially.  This  ground-breaking  technique  was  initially  quite  laborious,
involving  tedious  sample  handling  steps.  After  each  amplification  step  (cycle)  in  the
protocol, it was necessary to add a fresh enzyme to the reaction as the old one was being
denatured  due  to  high  temperatures11.  Only  after  a  thermostable  version  of  DNA
polymerase from T. aquaticus was combined with this novel technique did PCR became
routine, high-throughput, and commonplace in all  laboratories12,13. The next evolution of
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PCR was pioneered by Higuchi et al. through utilizing double-stranded DNA (dsDNA) dye
and  video  camera  technology.  This  setup  allowed  the  real-time  quantification  of  PCR
reaction14, also called qPCR. Combination of reverse transcription (RT), PCR, and real-
time monitoring (RT-qPCR) allowed for relative quantification of any mRNA species with a
known sequence.  Later,  as the technology developed,  it  became possible  to  measure
multiple genes in one reaction with fluorescently labeled probes. Still, RT-qPCR had some
shortcomings. It is a low-throughput method and limited to just a handful of genes at a
time, and as the Northern blot method, it cannot be used to detect novel transcripts. These
techniques are invaluable in targeted studies with known genes yet leave the rest of the
vast transcriptome unstudied.
The initial estimate for the number of genes in the human genome ranged from 50,000 –
90,00015. Since the first draft of the human genome in 2001, the more accurate estimates
have put that number to be around 20,00016. As of February 2021, Ensembl notes 20,437
protein-coding gene transcripts, 16,900 lncRNAs, 4,867 small non-coding RNAs, and an
additional 2221 miscellaneous RNAs17.
Need drives innovation; a higher throughput method was required to analyze the whole
transcriptome; the solution came from using the hybridization method in an arrayed setup.
The basic principle is as follows: short DNA sequences (probes) of the genes of interest
were attached to a glass or silicon chip in a grid-like fashion. RNA or cDNA of the sample
of interest is applied and visualized with dsDNA binding dye. More copies of one gene
equate to a brighter signal. In 1995 the first study was published, mentioning “microarray”
in  its  title18,  and  it  measured  45 A.  thaliana genes  simultaneously18.  Two  years  later,
Lashkari et al. developed a microarray that contained probes for all of the open reading
frames  (ORFs)  in  yeast  (2,479  in  total)19.  The  technology  was  subsequently
commercialized,  and  whole-genome  transcriptome  studies  in  humans  and  model
organisms sky-rocketed (Fig.1.1 B). Many different microarrays were made to profile all
known  genes,  SNPs,  and  alternative  splicing  of  mRNA20.  Microarrays  enabled  high
throughput and standardized workflows that are cost-effective  and remain competitive to
date.  Despite  all  the  possibilities  that  microarrays  offer,  they  are  not  without  their
drawbacks. They only allow measuring known transcripts (known sequences). As such, it
is  impossible  to  discover  completely  novel  transcripts  or  unexpected  polymorphisms,
alternative  splicing,  or  editing.  Also,  the  sensitivity  of  microarrays  is  significantly  lower
compared to RT-qPCR, which is especially relevant when analyzing genes with low levels
of expression21.
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Figure 1.1 (B)  Popularity of  methods.  The total  number of  datasets found per year  in PubMed.gov.  (C)
Sequencing cost per one human genome in blue and per one megabase (Mb) in red22.
A solution  to  all  of  these  problems  came  from  another  combination  of  technologies.
Combining reverse transcription with PCR and DNA sequencing, it became possible to use
any DNA sequencing platform to get accurate and sensitive gene expression information.
Now,  only  the  cost  was  an  issue,  since  in  RNA-sequencing  (RNA-seq),  unlike  DNA-
sequencing, it is not only the sequences themselves but also the abundances of those
sequences that are of interest. 
This problem was solved thanks to another mega-project. In the early to mid-2000s, driven
by  the  Human Genome Project,  the  next  generation  of  sequencing  technologies  was
coming of age16. Until then, RNA-seq was limited by the enormous cost of sequencing in
general (Fig.1.1 C). Next-generation sequencing (NGS), also called 2nd generation, uses
microfluidic  chips  to  run  and  measure  millions  of  simultaneous  reactions.  Also  called
sequencing  by  synthesis,  it  was  developed  initially  by  Solexa  and  later  acquired  by
Illumina. NGS offers cheaper and much higher throughput sequencing than conventional
Sanger sequencing23. 
The first  RNA-seq paper  was published in  2006,  analyzing  the  prostate  cancer  cell  line
LNCaP with a combination of expressed sequence tag (EST) and sequencing by synthesis
approach24. By 2008, sequencing price had dropped 100-fold since 2001 (Fig.1.1 C), and
Illumina offered more than a gigabase of data in one sequencing run. These developments
positioned RNA-seq to become a widely used technique to this day. RNA-seq offers far more
accurate and sensitive transcriptome profiling than any other method, and it overcomes all the
main limitations of Northern blots, qPCRs, and microarrays since it can detect completely
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novel transcripts, alternative splicing, SNPs, polymorphisms, and RNA editing4. Despite the
falling cost of sequencing and all the advantages, it took more than a decade for RNA-seq to
overtake microarrays in the number of datasets produced per year (Fig.1.1 B). Currently, the
most significant issues with RNA-seq are all associated with the method of sequencing. NGS
offers a very high throughput and fidelity DNA sequencing, but it  is limited to short read
lengths (50-300bp). Short read lengths make it necessary to sequence more deeply to later
combine the reads into one continuous transcript or contig during the data analysis, increasing
the costs. Also, because of short read lengths, it is challenging to align repetitive sequences,
although that specific drawback rarely affects RNA-seq4,25.
Another  problem with  current  DNA sequencing  methods  is  the  need  for  amplification
before  sequencing,  leading  to  several  additional  difficulties.  First,  no  direct  RNA
sequencing is possible, as PCR works only on DNA. Second, the amplification of different
sequences is not uniform and, therefore, can cause amplification bias. Here, high numbers
of short reads with the same sequence could mean either a very abundant transcript or an
uneven amplification4.  Third,  increasing  the  input  material  (number  of  cells  in  a  given
sample) reduces the number of cycles needed for a PCR amplification but comes at the
cost of cellular resolution. RNA-seq is often performed on a collection of cells either from a
tissue or cell  culture, and as a read-out, we get an average expression level of all the
genes  in  the  sample.  To  achieve  a  single-cell  resolution  in  RNA-seq,  more  sensitive
sequencers and innovations in library preparation were needed.
1.2 Single-cell RNA sequencing
The NGS platforms have seen significant improvement since their inception. The sequencing
accuracy, sensitivity, and throughput, along with molecular biology methods, have all gotten to
the point that it has been possible to analyze whole transcriptomes of single cells for over a
decade now. The first single-cell dataset was published by Tang et al. in 2009 when they
sequenced four mouse blastomeres, the cells that form after a fertilized egg cell divides. The
choice of these was deliberate as they are one of the biggest cells in a mammalian body and
contain a lot of RNA,  making working with these cells much easier.  Within five years, the
average number of cells captured and sequenced in a single-cell study grew to hundreds, and
after a decade, it was in the hundreds of thousands26 (Fig.1.2 A). Every year more and more
single-cell RNA-seq (scRNA-seq) datasets are published. At this rate, in another five years, it
is likely to overtake bulk RNA-seq as the most common transcriptomics tool (Fig.1.1 B).  
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Despite the myriad of different scRNA-seq protocols, the main parts of these methods fall
into two categories. The first  and the oldest methods involve some way of separating and
choosing  cells  (FACS,  laser  dissection,  etc.)  and  then  running  the  library  preparation
reactions in microtiter plates or other small vessels. The second main group of methods is a
lot more automated and requires less hands-on time. It utilizes microfluidic technologies and
specialized microchips to separate the reactions from each other, while they are usually still
carried out on the same microfluidic chip.
An offshoot of that technology uses microfluidic chips to separate single cells into small lipid
droplets containing the required reagents and primers for the first steps of library preparation.
After lysis and RT, part of which is also cDNA barcoding in the droplet, all the samples are
mixed and handled together to save on reagents and time. The first such protocol was aptly
named Drop-seq, and it offers one of the highest throughputs of all scRNA-seq methods28. 
This need to make scRNA-seq more affordable also brings us to the next big division in the
library preparation methods; full-length mRNA vs. tag-based sequencing. All high throughput
single-cell  methods  are  tag-based  end-counting  (usually  3´  end  of  mRNA molecules)
methods that generate partial cDNA transcripts. Sequencing these tags results in a count
table of genes, where the numbers signify how many times each tag (gene) was captured
per cell29–31. This method, also called digital gene expression (DGE), is an excellent and
cost-effective  way  to  capture  and  sequence  mRNA  from  vast  numbers  of  cells
simultaneously.  The first  method to  do  this  was single-cell  tagged reverse  transcription
(STRT-seq). They prepared single-cell libraries of 96 cells and at the same time also only
captured the 5´ ends of mRNAs for sequencing32. However, by focusing only on a portion of
any given transcript,  it  is  impossible  to  derive information about  other  gene expression
mechanics, including alternative splicing or RNA editing. 
To overcome this  limitation,  one would need to  produce full-length  cDNA transcripts  of
mRNAs. The first  protocol  to  achieve this  for  single cells  was based on the Switching
Mechanism at the 5′ end of RNA Template or SMART method33–35. Full-length methods have
much-reduced throughput  and increased sequencing cost.  However,  some collaborative
efforts  have produced full-length  cDNA libraries  of  single  cells  and sequenced them in
comparable numbers to tag-based methods. 
One of these was the Tabula Muris Consortium. In 2018 they published two single-cell
datasets  in  parallel;  one  full-length,  containing  44,949  single  cells  and  one  tag-based,
containing 55,656 single cells produced using a commercial solution from 10X Genomics36.
Still, the scope of projects like these is beyond the majority of standard laboratories, as costs
are prohibitively high. 
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Figure 1.2 (A) Reported numbers of single cells in publications ordered by date. Data points are colored by
the type of library preparation. Major milestones are indicated with labels. Figure adapted from27. (B) Single-
cell  RNA-seq vs. bulk RNA-seq. scRNA-seq can reveal cellular heterogeneity in a population of cells.  It
allows the detection of novel cell types and cell development inference. 
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One more major difference to note is the way cDNA is amplified in a given protocol. Again,
two options exist; the amplification can be either linear or exponential. The latter is always
based on PCR, but the former uses in vitro transcription or IVT to produce enough RNA
transcripts  based  of  (barcoded)  cDNA that  can  be  reverse  transcribed  yet  again  and
sequenced like in any other method. Although IVT protocols for scRNA-seq were among
the first (CEL-seq), they were quickly overtaken by PCR-based methods. The main reason
to use IVT is to avoid amplification bias37, but the bulk of that problem has been solved by
incorporating Unique Molecular Identifiers (UMIs) during the RT step. There will be more
on that in chapter 4.1. 
Interestingly only microfluidics platforms have achieved commercial success. The first one
on the market was Fluidigm’s C1 system, followed by 10X Genomics Chromium, only two
years later.  The C1 system offers full-length  coverage and a choice  between  different
library preparation methods STRT-seq or SMART-seq, but by its design, it is limited to
~1000 cells per run38. 10X Chromium is directly based on Drop-seq, and like Drop-seq, it
has one of the highest throughputs of all the platforms. 10X has also managed to bring a
certain standardization and quality control to the market. It is exceedingly simple to use,
and it offers a combination of multi-omics approaches such as cell surface protein capture
and constant improvements to keep this platform competitive39,40. 
Regardless of how the library preparation is performed, all of them are still sequenced on
second-generation (NGS) platforms, which dictates specific requirements for the libraries
(see chapter 1.1). These will  inevitably change as technologies develop. Already since
2019,  single-cell  datasets  have been published41–43 that  used  what  is  called  the  third-
generation sequencing platforms. The main difference between the NGS and the third-
generation  is  the  read  length.  The  two  leading  platforms:  Single-Molecule  Real-Time
sequencing SMRT-sequencing by PacBio and Nanopore sequencing by ONT, offer reads
that  are  kilobases  long,  compared  to  200-300  bases  offered  by  Illumina.  PacBio’s
approach  involves  modified  polymerase  and  fluorescently  tagged  dNTPs.  DNA to  be
sequenced is circularized and attached to the polymerase, which proceeds to synthesize a
new complementary strand. With each addition of a dNTP, a light signal is given off, and
the  bases  are  read  in  real-time.  To  achieve  higher  accuracy,  the  same  sequence  of
circularized DNA is “read-through” multiple times (up to 20X)44 (Fig. 1.2 C). 
ONT  takes  a  slightly  different  approach  to  PacBio.  A  nano-sized  pore  is  used  in
conjunction with a motor protein that feeds a single-stranded DNA (or RNA) through it
under an electric field. Unlike any other sequencing method, Nanopore sequencing can be
used for  direct  RNA sequencing and direct  genomic  DNA sequencing that  can reveal
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epigenetic modifications41 (Fig. 1.2 C).
Both of these platforms are highly modular, and by repeating the main elements (pores or
polymerase chambers), it is possible to increase the throughput, although currently, they
are still  only now catching up to Illumina. Both technologies had similar troubles in the
beginning, the speed of polymerase for SMRT-seq and the speed of motor protein for ONT
was extremely high, and it was necessary to figure out ways to slow them down to get a
more accurate read-out. Currently, the third-generation sequencers are all troubled by high
error  rates45,46. One way to overcome this problem is to combine  the second and third-
generation sequencing platforms.
Figure  1.2  (C)  Overview  of  3rd generation  sequencing  platforms.  SMRT-sequencing  from  PacBio  and
Nanopore sequencing from Oxford Nanopore Technologies. Figure adapted from47.
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A protocol called ScNaUmi-seq does just that by using the Chromium from 10X Genomics
with NGS for high accuracy barcode reads and nanopore from ONT for full-length reads41.
One drawback of ScNaUmi-seq is still the sequencing cost, as it effectively doubles it by
sequencing the same libraries on two different platforms.
In  principle,  it  is  possible  to  apply scRNA-seq in  place of  regular  bulk  RNA-seq.  Still,
because of certain limitations and differences in scRNA-seq methods, it is more common
to  use  it  for  experiments  where  high  sensitivity  is  not  required.  Although  single-cell
technologies have improved immensely,  the low mRNA capture rate remains the main
limitation. Droplet-based platforms capture only about 10-30% of the total mRNA in a cell.
This number is slightly higher for plate-based methods (up to 60%)48,49. 
The benefits of scRNA-seq are manyfold. It  can detect gene expression changes on a
single-cell  level,  reveal  the  cellular  heterogeneity  of  tissues,  detect  novel  and  rare
subtypes  of  cells,  shed  light  on  cellular  differentiation  and  identify  other  population
dynamics like cell cycle50 (Fig.1.2 B).
Further  developments,  especially  those  related  to  nanopore  sequencing,  seem  very
promising – not only would high-accuracy Nanopore sequencing offer cheap and high
throughput full-length RNA-seq, but it also could be used for direct RNA sequencing and
real-time mapping of the reads51,52. The implications of such technological achievements
are profound and exciting.
1.3 Cellular differentiation and scRNA-seq
All somatic cells in a multicellular organism contain essentially the same DNA, yet as the
organism develops, gene expression changes dictate how the cell will  differentiate and
acquire new functions53. Most often, this process is described as a pebble rolling down the
hill.  At the beginning of the journey,  a cell  has many diverging paths ahead, but  as it
progresses,  its  choices become more restricted  and the  path  more defined,  as  do its
functions  and  cell  type.  The  general  shape  of  this  landscape  is  defined  by  gene
expression54.  Cells  differ  from  each  other  morphologically  and  functionally,  and  both
differences  are  primarily  determined  by  the  proteins  they  produce.  Therefore,  the
fundamental  difference  comes  down  to  gene  regulation  and  expression.  Genes  are
regulated at many levels: transcription, mRNA splicing, mRNA editing, mRNA export from
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the nucleus, translation, post-translational modification, but the most apparent phenotypic
regulation occurs at the level of transcription. This is also the most energy-efficient way for
a cell to regulate its function, which is also favored by evolution6. If a gene is not required,
it is best to avoid production rather than recycle an unused product.
Gene expression is affected by both internal programs as well as external stimuli. Cells
have to find a balance between reacting to these perturbations whilst maintaining their
course of  development55,56.  With  the  advent  of  scRNA-seq,  it  has  become possible  to
follow these changes and responses on a single-cell level. The opportunities provided by
the scRNA-seq are unprecedented. The ability to sequence thousands of cells as they
undergo developmental processes57,58 and detect changes in transcriptional programs in
response to stimuli  or  treatments59 will  continue to impact medicine and biotechnology
significantly.
To better deal with this data, a whole branch of analytical methods has been developed
since 2014, specifically for analyzing the dynamic processes in single-cell data60. The so-
called  pseudotime  analysis,  or  more  generally  –  trajectory  inference  (TI),  is  a  set  of
computational techniques that model how cells go through the cell cycle, differentiation,
and activation. Within a few years, these methods have become one of the most popular
tools for single-cell-omics61.
Figure 1.3 Main steps in pseudotime analysis workflow. In the first panel, the algorithm positions cells based
on their  similarity  to  other  cells.  Middle  panel,  the algorithm builds a  trajectory  to  capture the dynamic
processes in the dataset. Last panel, finding differentially expressed genes along the identified trajectories. 
The main idea of any TI analysis is to order the cells along a trajectory based on their gene
expression similarity. This trajectory can be linear, bifurcating, tree-shaped, or even circular.
TI analysis creates a (pseudo)temporal order in the data through which it is possible to
follow gene expression patterns as they change along the trajectory. Ultimately, TI aims to
rebuild the sequence that cells took in the developmental process, reveal the transcriptional
changes during that process and describe the potential cell fates (subsets)60 (Fig.1.3).
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1.4 Human T cell biology
T lymphocytes or T cells are an integral part of the vertebrate adaptive immune system.
They help to fight infections and tumors, but they can also respond to allergens or self-
antigens. T cells develop from hematopoietic stem cells that move from bone marrow to
thymus, an organ where they were first discovered and received their name from. In the
thymus,  T cells  undergo further  maturation and selection.  As one of  the first  steps of
maturation,  T  cells  undergo  T cell  receptor  (TCR)  rearrangement.  Following  that,  the
immature T cells develop into double-positive (DP) cells for both TCR co-receptors (CD4
and CD8), after which the selection process starts. How exactly the T cell selection occurs
in humans is still up for debate, but in mice, the DP cells undergo two selection rounds.
First, only the cells that interact with major histocompatibility complex class I or II (MHC-I
or MHC-II) on an antigen-presenting cell (APC) will  be selected for and receive a pro-
survival signal. The second round is the negative selection to remove the cells that react
too strongly to self-antigens presented by dendritic cells (DC). After the selection process,
either one or the other TCR co-receptor will be down-regulated, and naive CD4+ or CD8+ T
cells are ready to leave the thymus62.
Figure 1.4 T cell development in the thymus. Figure adapted from63.
The main difference between CD4+ and CD8+ T cells is how they function. CD8+ T cells,
also called cytotoxic T cells, destroy pathogenic cells (virus or bacteria-infected cells and
tumorigenic cells) by first identifying them through antigens presented to them on MHC-I
molecules6. After identifying target cells, CD8+ T cells release perforin, a protein capable of
forming pores in the target cell membrane, followed by the release of granzymes that enter
the affected cell  through the newly formed pores.  In the cell,  the granzymes trigger a
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signaling  cascade  that  eventually  leads  to  cell  death  by  apoptosis  (programmed  cell
death)64.  On the other hand, CD4+  T cells or helper T cells do not directly kill pathogenic
cells; instead, they help to direct the immunological processes that fight infections65.
In humans, unlike mice, mature T cells are present in the fetus from the early months of
pregnancy. Additionally, the percentage of naive vs. memory T cells changes throughout
the human lifetime. From birth to early adulthood, the majority of  T cells are new and
naive.  During  these  formative  years,  the  organism  is  constantly  encountering  new
antigens. Memory T cells start to accumulate from childhood, and the numbers level off
when a person enters adulthood. This new status quo is kept until the late stages of life
when  immuno-senescence  sets  in,  reducing  T  cell  functionality  and  increasing
inflammation66.  Recent  studies  have  revealed  an  intriguing  phenomenon  in
supercentenarians (people who survive to a very old age of 110+ years in good health and
cognitive state). They have elevated numbers of CD4+ T cells compared to a control group
of 50- to 80-year-old people. Those extra CD4+ T cells express very high levels of cytotoxic
genes  and are  primarily  (up  to  70%)  composed  of  only  ten  clonotypes,  and  just  one
clonotype can make up to 35% of the entire T cell population67. 
1.4.1 CD4+ T cell activation and differentiation
Unlike CD8+ T cells that only require clonal expansion to accomplish their function, CD4+ T
cells need an additional round of differentiation into specific “effector”  types to  fulfill their
role. To achieve this, a naive CD4+ T cell first needs to come in contact with a professional
antigen-presenting cell that is exhibiting an antigen on its MHC-II. TCR, together with  its
co-receptor CD4, binds the MHC-II as the first of three “classical” signals68. The second is
the costimulatory signal. CD28, one of the best-characterized receptors for co-stimulation
on T cells, binds CD80 and CD86 on APCs. Receiving the first two signals is enough for
the naive CD4+ T to cell leave quiescence and start the clonal expansion up to millions of T
cells  that  all  recognize  the  same  antigen.  To  limit  and  control  this  expansion,  the
proliferating  T cells  themselves  transiently  produce  CTLA-4,  a  molecule  that  binds  to
CD28,  and  instead  of  the  activation  signal,  transmits  an  inhibitory  signal69.  To  avoid
inappropriate signaling,  APCs only express CD28 ligands a short  time after  coming in
contact with a pathogen. When TCR binds the MHC-II without a costimulatory signal, the
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activation is instead terminated70,71. 
Lastly,  the  third  signal  is  transmitted  to  the  activated  cells  through  the  immediate
microenvironment.  Cytokines released by APCs will  determine the cell  fate of T helper
cells72 (Fig. 1.41). Another factor that might play a role in T cell fate decisions is the affinity
by which antigens bind to the TCR. For example, Constant et al. showed that low-affinity
vs.  high-affinity  binding  of  TCR  resulted  in  different  T  helper  subsets73.  On  the
transcriptional  level,  the  cytokine signaling activates a family  of  STAT proteins  (Signal
Transducer  and  Activator  of  Transcription)  that,  together  with  lineage-specific  master
transcription factors, regulate the differentiation into memory T cells (T effector cells)74–77
(Table 4.1.2). 
Figure 1.4.1 T cell activation. APC has an antigen on the MHC-II (the red dot). TCR recognizes the antigen.
The  CD28  molecule  recognizes  the  costimulatory  signal.  The  release  of  cytokines  transmits  the  third
polarizing signal into the microenvironment. Created with BioRender.com. Modified from64.
Another  important  part  of  the  T  cell  activation  is  an  apoptotic  process  called
activation- induced  cell  death  (AICD).  AICD  has  multiple  functions.  Premature  T cells
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undergo AICD during the normal developmental selection process78. AICD is also part of
the T cell response and helps  to  limit  the expansion of T cells  after  the activation and
possibly plays a role in the differentiation of T helper subsets79,80. AICD is also responsible
for the contraction phase, which is part of the T cell immune response. The normal course
of T cell immunity has three phases: expansion, contraction, and memory phase. In the
contraction phase,  AICD  causes a massive decline in T cell numbers, after which only
around 5% of the T cells that went through activation and proliferation remain and make up
the memory T cells. This is the beginning of the memory phase81.
1.4.2 Types of CD4+ T cells
As with T cell development, most of what we know about differentiation and types of T
helper cells comes from the murine system. The pioneering work by Mosmann et al. in
1986 led to the discovery of two functionally different types of CD4+ T cells in mice. They
named these two TH1 and TH2, and they are distinguished from each other based on the
cytokine expression profile in response to various stimuli.  Further studies showed that
specific transcriptional programs are responsible for these cell fates. In 1997 Zhang et al.
showed the  dependence  of  TH2  lineage  on  GATA3,  a  transcription  factor  (TF),  and  a
known IL-5 promoter activator. Followed by Szabo et al. in 2000, when they described a
novel TF called T-bet (TBX21), responsible for TH1 lineage commitment. 
The function of TH1 cells is to signal to phagocytic and cytotoxic cells, to involve them in a
fight against intracellular pathogens. TH1 cells can also help to fight intracellular bacteria
that have managed to survive in macrophages. TH1 cells can activate those macrophages
to fight the intracellular pathogens after detecting the bacterial antigens on their surface. 
TH2 cells, on the other hand, help to deal with bacterial toxins and extracellular pathogens
by facilitating antibody production82. TH2 cells are specifically required for B cells be able to
start producing Immunoglobulin E (IgE) antibodies, whose main role is the defense against
parasites. Because IgEs are also responsible for many types of allergic reactions, such as
conjunctivitis,  asthma,  rhinitis,  and  food  allergies,  that  makes  the  TH2  cells  doubly
interesting6,83. This TH1-TH2 dichotomy lasted until 2005 when the third subset of T helper
cells was discovered – TH17 cells. To this end, it was shown by Harrington et al. that TH17
cells develop in a TH1 and TH2 independent manner. Although TH17 cells seem to have
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some role in early defense mechanisms and they are thought to be positive regulators of
immune response (increased inflammation), there has been a lot more research into TH17
cells that are implicated in autoimmune diseases, such as psoriasis, MS, Crohn’s disease,
and arthritis84,85. 
These classical TH types of the adaptive immune system also have their counterpart in the
innate branch of immunity. The innate lymphoid cells or ILCs are an integral part of innate
immune response, and similarly to T helper cells, there are three main subtypes of them. 
The first group contains natural killer (NK) cells and ILC1 cells. They produce IFN-γ when
activated, and their transcriptional program is controlled by TBX-21, similarly to TH1s. The
second group, ILC2, produce TH2 type cytokines, such as IL-4, IL5, and IL-13, and like
TH2, the transcription factor GATA3 controls their development. The last group of ILCs, the
ILC3, are similar to TH17 cells in that their development depends on the TF RORγt, and
they produce IL-22 when activated86,87. However, these groups were first defined in mouse
studies, and there is less conclusive evidence of ILC groups that are distinctly different
from NK cells in humans. The study of ILCs has been made more difficult due to the lack
of any specific lineage markers. The few single-cell studies so far have not been able to
find distinct ILC types from a mixed population of lymphocytes88–90, but there seems to be
some evidence of tissue specificity91.
Around the same time as TH17 discovery, additional  evidence had accumulated that  a
fourth group of T helper cells could be added to the list92. A specialized set of CD4+ T cells
was described in the context of B cell maturation and high-affinity antibody production that
takes place in germinal centers. This new subset was named follicular B helper T cells or
TFH93.  Another  addition  to  T helper  lineages  was  the  TH9  cells  characterized  by  their
expression  of  IL-9,  and  they  are  implicated  in  allergies,  inflammation,  and  anti-tumor
immunity94,95 (Table 1.4.1). 
Corresponding T helper subsets have also been found in humans, and the cell fates seem
to be similarly controlled by master transcription factors. GATA3 (TH2), TBX21 (TH1), and
RORC (TH17) all control similar pathways during T helper cell differentiation in humans as
they do in mice96–98. However, from the very beginning of T helper research, there were
some notable differences. For example this, TH1-TH2 dichotomy was not so clearly present
in humans as it  was in mice.  Many human T helper  cells produce some or all  of  the
cytokines from both TH1-TH2 lineage99,100. Not only that, but many immune cells such as
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monocytes, B-cells, eosinophils, NK-cells are capable of producing the “classical” TH1-TH2
cytokines as well101. Many recent studies have revealed a lot more plasticity in T helper cell
populations in humans, as well as in mice. In this regard, it is important to note that TH1,
TH2,  TH17,  and TFH all  have been successfully  reprogrammed to  produce cytokines of
some other T helper lineage102–105. This reprogramming is usually achieved by changing
the culture conditions to that of the desired lineage. Some of these plasticity experiments
have also been carried out in living organisms. In 2012, Panzer et al. showed that in vitro
polarized TH1 and TH17 can be turned towards TH2 fate in vivo. It has also been shown that
TH1 and TH2 cells commonly express both of the master regulators: GATA3 and TBX21 in
the mouse system and in the human system106. The discovery of several other tentative T
helper cell lineages such as GM-CSF (CSF2) producing THGM cells107,108, IL-22 producing
TH22 cells109 and TGF-β, IL-4, IL-10 producing TH3 cells110, has made it increasingly more
apparent that well-defined subsets of T helper cells as such might not exist in vivo. At least
not  in  clear  and discrete  sub-populations.  The entire  T helper  system might  be  more
complex than simple low parametric read-outs suggest.
Table 1.4.2 T helper cell subsets with cell fate-specific master regulators and their role in immunity.
Therefore, it is no surprise that scRNA-seq technologies hold the promise to finally clarify
the enigma on whether discrete, terminally differentiated T helper subsets exist or whether
the system contains more plasticity than originally thought. So far, most single-cell studies
have revealed a heterogeneous and continuous T cells population, regardless of whether
in  mice  or  men67,111–114.  It  turns  out  that  defining  cell  types in  a  very  high-dimensional
dataset is more complicated than in more conventional read-outs like ELISA and FACS. It
is relatively easy to tell cell  types apart based on the expression of a few cytokines or
receptors, but if the entire transcriptomes of those cells are compared, these differences
will become less apparent115.
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Cytokine Profile IL-9 IL-4, IL-21
Master TF GATA3, STAT6 BCL-6, STAT3
Role in defence Mucosal barriers
MS, Diabetes Lupus, GPA
TH1 TH2 TH9 TH17 TFH
IFN-γ, IL-12, TNF
      IL-4. IL-5,      
IL-13


























Moreover,  cell  type  assignment  in  scRNA-seq  data  is  commonly  performed  on
dimensionality  reduced  data.  Dimensionality  reduction  (DR)  methods  fall  into  two
categories,  linear  dimensionality  reduction  (LDR),  such  as  PCA or  LDA,  or  nonlinear
dimensionality reduction (NDR) methods like tSNE, UMAP. For single-cell data, NDRs are
preferred as they are better at capturing the structure of data in lower dimensions. The
problem with this approach is that regardless of the method used, reducing the dimension
from tens of  thousands to  just  a  two  will  introduce substantial  distortions116.  It  is  also
possible to  perform the clustering (cell  type assignment)  in higher  dimensions,  but for
visualization purposes, two or a maximum of three dimensions is all  that is practical to
depict. The current understanding is that the gene expression data, especially scRNA-seq
data, is inherently low dimensional. As Heimberg et al. showed, genes are co-expressed in
modules, or transcriptional programs, which vastly reduces the number of dimensions from
the  number  of  all  genes  down  to  the  number  of  modules  in  a  given  cell  type.  The
significant  variation  and  dominant  transcriptional  programs  should  be  preserved  in
reduced dimensions117, but the question remains, how to determine the optimal number of
dimensions for DR methods and how reliable are such methods for cell-type assignment.
For now, very little research has been put into discovering the inherent pitfalls in using DR
data for downstream analysis116,118,119.
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2  Aims of the Study
As discussed above, cellular differentiation is a complex topic,  but recent advances in
transcriptomics  technologies have made the study of these processes easier than ever
before. T helper cells are responsible for a great many immune responses and functions in
humans and other vertebrates, but in order to function properly, they need to go through
many rounds of  differentiation.  Therefore,  it  is  vital  to  have an in-depth  knowledge of
helper  T  cell  activation  and  differentiation  processes,  to  develop  therapies  and  cure
associated diseases. However, despite decades of research, there are still several open
questions concerning helper  T cell differentiation. When and how exactly is the cell fate
determined, how do cells retain their effector functions, and how do T cell subsets differ
from each other transcriptionally on a single-cell level.
Our first objective was to set up and optimize a single-cell sequencing platform and test its
capabilities in  biologically  meaningful  situations.  The second objective was to  use this
platform to study human T-helper cells. More specifically, we wanted to study the activation
and differentiation of helper  T cells to identify and describe  the types of memory T cells
and unravel time-dependent regulators of cell fate.
While Chapter 4 focuses on the first aim, the second aim is explored in chapter 5. 
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3 Materials and Methods
3.1 Materials
The consumables for sterile and non-sterile laboratory work were purchased from the
following manufacturers: Bioplastics, Bio-Rad, Biozym, Corning, Greiner, Labomedic,
Neolab, Sarstedt and VWR. The consumables for sterile and non-sterile laboratory work
came from the  following manufacturers:  Bioplastics,  Biorad,  Biozym,  Corning,  Greiner,
Labomedic, Neolab, Sarstedt, Starlab, and VWR.
3.1.1 Antibodies and FACS reagents
Name Supplier Application Dilution
CCR7‐BV421, G043H7, mouse IgG2a BioLegend FACS 1:25
CD14-FITC, mouse BLD-301804 BioLegend FACS 1:50
CD19-BV711, mouse BLD-302246 BioLegend FACS 1:50
CD3‐PerCP, clone UCHT1, mouse IgG1 BioLegend FACS 1:100
CD4‐Qdot605, clone S3.5, mouse IgG2a Thermo Fisher FACS 1:100
CD45RA‐PE, clone HI100, mouse IgG2b BioLegend FACS 1:200
IFN-γ-BV711, clone B27, mouse, IgG1 BD Bioscience FACS 1:100
IL-4-PE, clone 8D4-8, mouse, IgG1 BD Bioscience FACS 1:100
LIVE/DEAD™ Fixable Near-IR Dead Cell 
Stain Thermo Fisher FACS 1:1000
NucBlue™ Live ReadyProbes™ Thermo Fisher FACS 2 drops/mL
3.1.2 Buffers and solution
Homemade Buffers Components (end conc.)
50X TAE Buffer
242g Tris
57.1 ml Acetic acid
18.6g EDTA 2Na-2H2O 
add water to 1L
Direct Lysis Buffer 0,2 mg/ml Proteinase K
1 mM CaCl2 
3 mM MgCl2 
1 mM EDTA 
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1% Triton X-100 
10 mM Tris pH 7,5
FACS buffer
2mM EDTA 
2% FCS in PBS
TE Buffer
10 mM Tris-Hcl
1 mM EDTA Na2
3.1.3 Cell culture media and reagents
Cell Culture (media and reagents) Supplier













Phorbol 12‐myristate 13‐acetate 
(PMA) Enzo Life Sciences
Rabbit Anti-Human IFN-gamma PeproTech
Recombinant human IL-12 R&D Systems
Recombinant human IL‐2 R&D Systems
RPMI 1640 Gibco
Sodium Pyruvate Gibco
3.1.4 Chemicals and reagents
Chemical and Reagent Supplier







DNA AWAY Thermo Fisher
DNA Stain G Serva
dNTPs Genaxxon
EDTA 0.5M Invitrogen
Ethanol Ultrapure Carl Roth










UltraPure Distilled Water Invitrogen
3.1.5 Enzymes and enzyme buffers
Enzymes and buffers Supplier
5x DNase Buffer Thermo Fisher
5x Reverse Transcriptase 
buffer Thermo Fisher
5X SuperScript IV RT buffer Invitrogen














Cell Line NucleofectorTM Kit T Lonza
High Sensitivity DNA Kit
DNA Kit Agilent
IFN-gamma ELISA R&D Systems
IL-13 ELISA R&D Systems
IL-4 ELISA R&D Systems
MiSeq Reagent Kit v2 (300-
cycles) Illumina
Naive CD4 T cell isolation kit II,
human Miltenyi Biotec
Nextera XT DNA Library 
Preparation Kit Illumina
Pan T cell isolation kit human Miltenyi Biotec
Quant-iT™ PicoGreen™ 
dsDNA Assay Kit Invitrogen
RNAdvance Viral Extraction Kit Beckman Coulter 
TNF ELISA BD Biosciences
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3.1.7 Primers
SCRB-seq Barcoded Primers (96) contain unique 8 bp long barcodes (indicated with 
XXXXXXX in the table below) and unique molecular identifiers UMI indicated with N – Any 
base with a V – Any base except T to make them anchored. 















































































sgRNAs  oligos  are  composed  of  the  5’-GGAAAGGACGAAACACCG-3’  sequence,
followed by the specific target site in the table below without PAM sequence, followed by





















BD FACSMelody™ Cell Sorter
Biomek® FXp liquid handler
C1000 Touch Thermal Cycler
Centrifuge 5430
Chemidoc imaging system






Spark® 20m multimode Reader





















3.2.1 Agarose gel electrophoresis
DNA fragments  were  analyzed by  agarose gel  electrophoresis.  For  a  1% gel,  1  g  of
agarose was dissolved in 100ml of 1x TAE buffer and heated in the microwave until the
solution cleared completely. dsDNA dye SYBR™ Green was used at a 1:100 000 dilution.
Loading dye from Thermo (cat. R0611) was used to prepare the samples before loading
them onto the gel. Thermo 1kb plus DNA ladder (cat. 10787018) was used for sizing the
samples. DNA fragments were separated under 100 V for 45 min. and imaged with Biorad
Chemidoc system. 
3.2.2 Cell Lines
BLaER1: these cells are a subclone of a human B cell lymphoma cell line engineered to
express a construct – C/EBPαER-GFP. Treating these cells with β-estradiol converts them
into functional macrophage-like cells120.
3.2.3 Cell culture methods
Incubators used for culturing all cells in this work were kept at 37° C and increased CO2
concentration (5%).
BLaER1 media contained RPMI 1640 supplemented with 10% FCS, 1% sodium pyruvate,
100 U/mL penicillin-strepomycin.
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Transdifferentiation  of  BLaER1 cells:  BLaER1 cells  were  plated  into  96-well  (flat-well)
plates  in  70  000  cells  per  well  concentration.  Transdifferentiation  media  contained  10
ng/mL IL-3, 10 ng/mL M-CSF, and 100 nM b-estradiol.  Cells were expanded for 5 days,
after which they were harvested for the single-cell experiments. 
Primary  human  CD4+ T  cells  were  cultured  in  Advanced  RPMI  1640  medium
supplemented with 5% HS, 10 mM HEPES, and 100 U/mL penicillin-streptomycin.
T cell differentiation: 48-well culture plates were prepared one day before the experiment.
Wells  were  coated  by  adding  100  μL of  PBS containing  (1  μg/mL)  Anti-Human  CD3
Antibodies overnight. Wells were washed/blocked with Advanced RPMI 1640 media once
before the T cells were plated  at 250 000 cells per well  in 500 μL containing 0.5 μg/mL
Anti-Human CD28 Antibodies and IL-2 (50 U/mL).
For TH1 skewing condition,  additional IL-12 5 ng/mL was added. For TH2 condition, anti-
IFN-γ antibody (1 μg/mL) and IL-4 50 ng/mL was added. The non-skewing condition was
kept as is. Media was exchanged every 3 days by removing half of the old media and
adding 250 μL fresh media containing IL-2 (50 U/mL).
3.2.4 Stimulation of immune receptors with specific agonists in BLaER1 cells
Unless  otherwise  stated,  the  BLaER1  cells  were  stimulated  with  LPS  2  ng/mL  or
transfected with 200 ng/well of HT-DNA in combination with 0.5  μl lipofectamine  or left
untreated. After 2 hours, the cells were harvested and proceeded to cell-sorting. 
3.2.5 PBMCs and CD4+ naive T cell isolation
PBMCs  were isolated from heparinized human blood of  healthy consenting volunteers
(according  to  the  Declaration  of  Helsinki  and  approved  by  the  responsible  ethical
committee) using a Bicoll (Merck cat. L6115-BC) density gradient centrifugation, red blood
cells were removed with RBC lysis buffer (BioLegend cat. 00-4333). 
T  cells  were  purified  either  directly  from  PBMCs  or  CD14-depleted  flowthrough  after
monocyte isolation with Naive CD4+ T Cell Isolation Kit II (Miltenyi). 
FACS purified T cells were sorted from enriched T cells for which Pan T cell isolation kit
(Miltenyi) was used on PBMCs.
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3.2.6 KO cell-line generation by CRISPR-Cas9
CHUCK-/-, IKBKB-/-, IKBKE-/-, IRF3-/-, IRF7-/-, MYD88-/-,TBK1-/-, and TICAM1-/- KO generation
in BLaER1 cells was carried out by Thomas Ebert. 
RELA-/- KO was generated by Dennis Nagl. 
KOs in T cells (GATA3-/-  and TBX21-/-) were generated by Andreas Linder
BLaER1 KO generation: 
KOs in BLaER1 cells were generated as described in121. Briefly: sgRNA was from our own
library122.  One  day before electroporation, BLaER1 cells were  plated in a 96-well  at  200
000 cells per  mL.  The next day the cells were  suspended in 250  μl Optimem medium
containing 5 μg of target plasmids; both for the expression of Cas9 and gRNA. Cells were
incubated  at  room  temperature for  10  minutes,  transferred  to  4  mm  cuvette  and
electroporated with a Gene Pulser Xcell™ Electroporation System from Biorad using the
following settings:  exponential decay protocol – 265 V, 975 μF,  and  700 Ω.  Cells were
plated in a 6-well plate in a pre-warmed normal RPMI medium.
One day after, cells were sorted for BFP positivity. 5% highest positive cells were sorted,
then plated by limiting dilution cloning into U-bottom 96-well plates. Approximately 3 weeks
after living colonies were identified by absorption at 600 nm with Spark20M microplate
reader. 1-2 plates per KO were picked and reformatted into a new 96-well plate. 
T cell KO generation: 
KOs were generated in  T cells  as described in  123.  Briefly:  CD4+ T cells  were  kept  in
medium overnight following the isolation. Before nucleofaction, T cells were washed with
PBS  once, and per KO,  2 million cells were resuspended in 20 μl P3 buffer. CRISPR‐
Cas9‐RNPs were prepared as follows: first chemically stabilized synthetic crRNA:tracrRNA
pairs (Table 3.1.8) were denatured at 95° C for 5 minutes after which they were incubated
at  for 30 minutes at  RT.  Combined gRNA (100 pmol) was mixed with recombinant NLS‐
Cas9(40 pmol) protein and incubated for 10 minutes at room temperature gRNA. 
Samples  and  RNPs  were  mixed  and  transferred  into  cuvettes,  and  the  EH100
nucleofaction program was carried out in the X-unit of a 4D nucleofector.  After,  the cells
were plated into a 24-well plate and kept in serum free Advanced RPMI 1640 media for up
to an hour. To enhance the survival, T cells were activated with anti-CD3 AB + anti-CD28
AB beads in 1:5 ratio in the presence of IL‐2 (50 U/mL) and 2.5% human serum. One day
post-activation T cells were subjected to limiting dilution cloning in a  U-bottom  96-well
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plate.  Monoclones  were  restimulated  on  day  7 with  2000  CD3/CD28 beads  per  well.
Approximately 2 weeks later, living colonies were identified by Cellavista, and 1-2 plates
per KO were picked and reformatted into a new 96-well plate.
3.2.7 Genotyping monoclones
Monoclonality and genotype of colonies (both BLaER1 and T cells)  were confirmed with
deep sequencing. For that 10 μL of sample from each well was taken and mixed with 10
μL of 2x Direct Lysis Buffer on a new plate (Lysis plate) and incubated at  65° C  for 10
minutes. Proteinase K was heat-inactivated at 95° C for 15 minutes. This lysate was used
as a template for the first step. To confirm the knocking out of a gene, it was necessary to
first amplify the gRNA target locus (PCR 1), and then in order to multiplex the samples for
deep sequencing, it is required to add barcodes to all the PCR 1 products. Primers for
PCR 1 are made of target specific sequences to amplify the genomic region of interest and
a universal adapter sequence where PCR 2 primers can attach. PCR 2 primers similarly
contain different sequence types; complementary sequence to PCR 1 adapters, barcode
sequence for multiplexing and Illumina sequencing adapter.  For  PCR 2 there were 16
forward primers and 24 reverse primes giving 384 unique barcode combinations. 
Both PCR reactions were set up as follows:
H20 – 3.5 μL
Phusion High GC Buffer – 1.2 μL
Fwd+Rev Primer (5 μM) – 1.2 μL
      dNTPs (10 mM) – 0.12 μL
      Phusion polymerase – 0.06 μL
   Template (lysate or PCR 1 product) – 1.0 μL
Total 6 μL reaction. 
Both PCRs were cycled under identical conditions: 
All PCR products were pooled and sequenced on an Illumina MiSeq Platform (single end
300 bp read  length) using  the v2 chemistry.  Outknocker124 v2. was used to analyze the
sequencing  results.  A clone  was  considered  a  KO  when  heterozygous  out  of  frame













3.2.8 Enzyme-linked immunosorbent assay – ELISA
Cytokine concentration in the supernatant of samples was measured by ELISA following
the manufacturer’s instructions. Briefly:  ELISA plates (high-binding) were coated with the
capture antibody in recommended amounts and using the kit specific buffer. The coating
was done overnight at 4° C. After coating, the plates were washed with PBS 3 times and
blocked with PBS containing 10% FCS for 1 hour at RT. Samples (diluted if needed) and
standards were loaded (50 μl) and incubated at RT. After 2 hours, the plate was washed
with  PBS again  5  times,  and  then  the  detection  antibody  and  streptavidin-HRP were
added. Plates were kept at  room temperature  for 1 hour in the dark.  Another  5  washes
followed by the  addition of  50  μl  of  TMB solution.  The reaction was stopped  with  2N
sulfuric acid. Gen5-Epoch microplate reader  was used to get the absorbance at  450 nm
and 570 nm.
3.2.9 Cell sorting
Cells were centrifuged for 6 min at 450 g and resuspended in the desired volume of FACS
buffer (2% FCS in PBS + 2 mM EDTA). Before sorting, cells were strained through 40 μm
filter.  Cells  were  sorted  using  a SONY SH800S or  a  BD FACS Melody  sorter.  When
possible NucBlue™ Live ReadyProbes™ Reagent (Hoechst 33342) staining was used to
exclude dead cells. 
3.2.10 Antibody staining for flow cytometry
Cells  were  harvested,  centrifuged  for  6  min  at  450  g,  supernatant  discarded  and
resuspended in 50 μL of FACS buffer (2% FCS in PBS + 2 mM EDTA). 1 μL of each
diluted antibody (see Table 3.1.1 for AB dilutions) was added. The sample was incubated
on ice in the dark for 25 minutes, after which 500 μL of FACS buffer was added. The
sample  was  then  centrifuged  for  6  minutes  at  450  g,  supernatant  discarded  and
resuspended in 500 μL of FACS buffer. All samples were kept in the dark and strained
through 40 μm filter prior to analyzing or sorting. 
31
3.2.11 Intracellular cytokine staining
Intracellular cytokine staining was performed on T cells. Multiple samples (250 000 cells
each)  were  stained  in  parallel  in  96-well  format.  Prior  to  staining,  all  samples  were
stimulated with PMA (50 ng/ml) + Ionomycin (1 µg/ml) for 2 hours to increase the cytokine
production or left unstimulated for controls. After stimulation  Brefeldin A (10 µg/ml)  was
added for another 2 hours to inhibit protein transport.
After stimulation, cells were washed once with PBS. BD Cytofix/Cytoperm™ Kit was used
as follows:
Samples were resuspended in 100 µl fixation/permeabilization solution and incubated at 4°
C for 20 min in the dark. 
150 µl BD Permeabilization/Wash buffer was added to each sample and centrifuged 450 g
for 5 min. The supernatant was discarded, and the cells were resuspended in 250 µl BD
Permeabilization/Wash buffer and centrifuge at 450 g for  5 min.  The supernatant  was
discarded, and cells were resuspended in 50 µl BD Permeabilization/Wash containing the
following antibodies: 2,5 µl IFN-γ AB, 2,5 µl IL-17 AB, and  5 µl IL-4 AB. 
The samples were incubated for 30 minutes in the dark and on ice, after which they were
topped up with 150 µl FACS buffer (PBS 2% FCS + 2 mM EDTA) and centrifuged at 450 g
5 min. The supernatant was discarded, and the cells were resuspended in 250 µl FACS
buffer. The samples were kept in the dark and on ice until analysis. 
3.2.12 Measuring DNA concentration
To assess the amount of dsDNA in a sample Quant-iT™ PicoGreen™ dsDNA Assay Kit
was  used.  A 1:400  working  dilution  of  dye  in  1X TE  (Tris  EDTA,  pH 7.0)  was  used.
Measurements were made in Greiner-CELLSTAR®-96 Chimney Style Well-Plates. Assay
solution was 150 μl, and 1 μl of sample per assay was used. A nine  well serial dilution
standard of known concentration lambda DNA was used (50 ng, 25 ng, 12.5 ng, 6.25 ng,
3.125 ng, 1.5625 ng, 0.78125 ng, 0,390625 ng and 0 ng blank) for absolute quantification.
Fluorescence was measured in a Tecan reader.
32
3.2.13 SPRI bead preparation
Homemade  SPRI  beads125 were  prepared from the  stock  bought  from GE Healthcare
SpeedBeads™  magnetic  carboxylate  modified  particles  (product  number:
45152105050250). An initial  solution of  PEG and  is prepared as required for application
(see table 3.2.11). NB! PEG will need around 1-4 hours to completely dissolve; warmer
temperatures and the constant mixing will speed up the process.
Table 3.2.13 SPRI bead reagents table.
The stock solution of SpeedBeads is resuspended vigorously  before  1 mL is transferred
into a 1.5 mL tube (300 μL if Pooling Beads are prepared instead). The tube is placed onto
a magnetic rack, and the supernatant is removed. The pellet is washed 2 times with Bead
Wash Buffer. After that, 1 mL of Bead Wash Buffer is used to resuspend the beads and
added to the initial PEG solution. The beads binding efficiency is directly dependent on the
salt and PEG concentration. To assay the beads cut-off and binding, a test clean up of low-
range DNA ladders is recommended. See DeAngelis et al. 1995 for more details. 
3.2.14 Solid Phase Reversible Immobilization (SPRI) bead-based DNA Clean-up
Standard SPRI beads that were prepared  according to  3.2.11 were used for cDNA and
PCR product clean-up and to facilitate buffer exchange. The beads were brought to room
temperature and vortexed thoroughly!  The sample was mixed with a required amount of
SPRI beads  depending on the size selection desired  (Fig  3.2.12) and incubated for 5
minutes  at room temperature. Samples were transferred to a magnetic stand, and  the
beads bound with  DNA were allowed to  migrate to  the magnet.  The supernatant  was
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NaCl 5M 10mL (1M) 20mL (2M) -
Tris-Hcl 1M 500μL (10mM) 500μL (10mM) 100μL (10mM)
EDTA 0.5M 100μL (1mM) 100μL (1mM) 20μL (1mM)
PEG 8000 11g (22%) 15g (30%) -
Igepal 10% 50μL (0.01%) 50μL (0.01%) -
NaN3 10% 250μL (0.05%) 250μL (0.05%) -
H2O up to 49mL up to 49mL up to 10mL






Bead Wash Buffer 
(10mL)
removed,  and  the  bead-DNA pellet  was  washed twice  with  100-200μl  80%  ethanol
(depending on the size of the pellet).  After the final wash, as much of ethanol as possible
was removed, and the pellet was air-dried for up to 5 minutes. The DNA was eluted from
the beads in the required amount of H2O or elution buffer (TE pH 8.0).
Figure  3.2.14 SPRI  beads  allow  for  size
selection depending on the concentration of
PEG+NaCl in the buffer. Because the beads
are  premade  in  the  binding  buffer
(PEG+ŃaCl)  in  effect,  the  size  selection
comes  down  to  the  volume  of  beads  (in
buffer) used.  Lower  ratios  allow  for
progressively  bigger  fragments  to  be
excluded. Each lane shows the result of 10
μl  of  DNA  ladder  being  “cleaned-up”  at
different ratios of beads. L – Ladder. 
3.2.15 Transposon-based library preparation
Nextera XT DNA Library Preparation Kit was used to perform the library preparation from
pre-amplified  cDNA libraries  (single  cell  and  bulk).  Library  preparation  was  performed
according to the manufacturer’s protocol with the following modifications: 
Tagmentation: cDNA for each sample was diluted to 0.2 ng/μL, and 5 μL (1 ng total) was
taken per library. Single-cell libraries were run in technical duplicates and bulk samples in
triplicates to avoid bottle-necks in the library complexity. Samples were mixed with 10 μl
Tagment DNA buffer and with 5 μl Amplicon Tagment Mix after which they were incubated
for 10 minutes at 55° C. 5 μL NT buffer was added to each reaction to stop the reaction.
After 5 minutes at room temperature, index PCR was started.
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Nextera Index PCR Master Mix was prepared for all samples as follows:
For 1 sample:
15 μl – PCR Mix
1 μl – P5NEXTPT5
8 μl – H2O
24 μL of this Master Mix together with 1 μL of i7 index primer was added to each sample.
Tagmented libraries were cycled as follows: 
Library clean-up: after PCR, libraries were cleaned up using the double-size selection
bead clean-up method.  The samples were mixed with  0.4X the volume of  beads and
placed on the magnet. The supernatant was removed and kept and mixed again with an
additional 0.4X of the volume of beads (the same volume as in the beginning, i.e. 100 μL
of sample + 40 μL of beads + additional 40 μL of beads). Samples were mixed and placed
on the magnet, and the normal clean-up process followed (see 3.2.14). This double-size
selection allows to remove un-tagemented long fragments and short primer-dimers in one
clean-up. 
Libraries were QC-ed on Bioanalyzer and pooled as desired for paired-end sequencing on
an Illumina HiSeq1500. 
3.2.16 SCRB-seq original protocol
Single cells were sorted directly into 96-well plates pre-filled with lysis buffer (5 μl of 1:500
dilution of Phusion HF buffer) as described in 3.2.10. After sorting, the plates were spun
down and immediately placed on dry ice.
The next day, the cells were thawed up at room temperature for 5 minutes then placed on ice. 
1  μl  of  Proteinase K (20 mg/ml)  solution was added to  each well,  and the plate was
incubated at 50° C for 15 minutes. This step was followed by sample desiccation – the
seal  was removed,  and samples were heated to  95° C  for  10 minutes.  Following the
desiccation, the plate was placed on ice and 1 μl of RT master mix, and 1 μl  of 2μM
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RT master mix for one 96-well plate:
40 μl 5X Reverse Transcriptase buffer
20 μl 10 mM dNTPs 
2 μl 100 μM E5 TSO
20 μl H2O
10 μl 1:300 000 ERCCs
12.5 μl Maxima H- Reverse Transcriptase
Total: 104.5
RT reaction was incubated at 42°C for 1:30 hours.
All  the  samples  were  pooled  and  mixed  with  Zymo  DNA Binding  Buffer  1:7  ratio,
respectively.  cDNA  was  cleaned  and  concentrated  as  by  Zymo  DNA  Clean  &
Concentrator-5 (cat. D4013) protocol. Samples were eluted in 17μl of H2O.
Leftover primers from RT were removed with Exonuclease I treatment as follows: 2 μl of
10X Exo I buffer and 1 μl of Exonuclease I is added to the sample and incubated at 37° C
for 30 minutes, followed by heat inactivation at 80° C for 20 minutes.
After this the samples are ready for pre-amplification. Sample DNA from previous step can
be directly used and a PCR reaction is set up as follows:
10 μl 5X Kapa HiFi buffer
1.5 μl 10 mM dNTPs
1.5 μl 10 μM SINGV6 primer
16.5 μl H2O
1 μl Kapa HiFi polymerase
The reaction is amplified according to the following program:
First safe stopping point. Samples can be kept at 4° C for overnight or frozen for longer 
periods. Pre-amplified cDNA is cleaned up following the standard SPRI clean-up (see 
3.2.14) and quantified (see 3.2.12).














3.2.17 SCRB-seq v.3 protocol
Single cells were sorted directly into 96-well plates as described in 3.2.10. Wells were pre-
filled with 4 μl lysis buffer.
Lysis buffer for one plate (96-wells):
380 μl H2O
44 μl 25 mM dNTPs
14 μl 40 U/μl RNAsine
3.4 μl 10% TritonX-100
Total: 440 μl
Additionally,  each well  also  contained 1  μl  of  2  μM Barcoded oligo(dT)  primers.  After
sorting, the plates were spun down and immediately placed on dry ice. 
The next day the cells were thawed up at room temperature for 1 minute followed by RNA
denaturing: samples were incubated at 70° C for 3 minutes and cooled down to 4° C then
immediately placed on ice. 
RT master mix for one 96-well plate:
283.5 μl H2O
210 μl 5X Reverse Transcriptase buffer
21 μl 100 μM TSO
10 μl 1:200 000 ERCCs
10.5 μl Maxima H- Reverse Transcriptase
Total: 535 μl
5 μl of this master mix was added to each well. RT reaction was incubated at 42° C for
1:30 hours.
All the samples were pooled and cleaned up using pooling beads (Table 3.2.13). Samples
were mixed in 1:1 ratio with the beads. After clean-up, samples were eluted in 17 μl of
H2O. Leftover primers from RT were removed with Exonuclease I treatment as follows: 2
μl of 10X Exo I buffer and 1 μl of Exonuclease I is added to the sample and incubated at
37° C for 20 minutes, followed by heat inactivation at 80° C for 10 minutes.
Following the digest, the samples are ready for pre-amplification. PCR mix can be added
directly to the samples from the previous step. 
Pre-amplification PCR reaction is set up as follows:
25 μl 2X Terra buffer
2.5 μl H2O
1.5 μl 10 μM SINGV6 primer
1 μl Terra polymerase
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The reaction is amplified according to the following program:
First safe stopping point. Samples can be kept at 4° C for overnight or frozen for longer
periods.  Pre-amplified cDNA is  cleaned up following the standard SPRI clean-up (see
3.2.14) and quantified (see 3.2.12).  Sequencing ready libraries are produced following
Transposon-based library preparation (see 3.2.15).
3.2.18 Low-input RNA-barcoding and sequencing protocol.
50 000 cells were harvested and washed per sample. Cells were transferred into RLT lysis
buffer containing 0.04M DDT and frozen for at least one day in -80° C. Addition of 1% of
Triton X100 was used for T cell low-input bulk sequencing. 
Samples were thawed and digested with 1 μL of 20 mg/mL Proteinase K per 50 μL of
sample and incubated for 10 minutes at 50° C followed by heat inactivation for 10 minutes
at 80° C.
After the digest, RNA was extracted with SPRI beads. Pooling beads (Table 3.2.13)  were
mixed with 1:1 ratio, and a standard clean-up process was followed. Samples were eluted
in 17 μL of H2O.
For T cell low-input bulk sequencing Beckman Coulter RNAdvance Viral Reagent Kit  (cat.
C63510) was used, and the accompanying protocol was followed. 
DNAse I  digest:  Since SPRI beads bind both DNA and RNA, a DNAse I  digest  was
required. Samples (17 μL) were mixed with 2 μL of DNAse I buffer (10x) and 1 μL of
DNAse I enzyme. The reaction was incubated at 37°C for 30 minutes, after which 1 μL
EDTA (100 mM) was added to each sample. Heat inactivation followed at 70°C for 10
minutes.
From this point on 5 μL of the sample was used as an input for RT, and the standard
SCRB-seq v.3 protocol (see 3.2.17) was followed with the following modifications: 














II. Barcoded oligo(dT) primers were added together with RT master mix. 
III. Pre-amplification cycles were reduced to 18 as bulk-seq has significantly more input
material. 
3.3 Data analysis
All  single-cell  data  was  sequenced in  the  Laboratory  for  Functional  Genome Analysis
(LAFUGA,  Gene Center,  LMU Munich)  using  a  HiSeq1500 machine.  Sequencing was
always paired-end, and the length varied from 50 to 100 bp. The low-input bulk RNA-seq
of T cells was sequenced in Max Planck Institute of  Biochemistry’s NGS Core Facility
(Martinsried) using a NextSeq 500. 
Raw cytometry data was analyzed using the Flowjo software.
3.3.1 Demultiplexing, Mapping, and Gene Counting
Whenever possible FASTQ demultiplexing, QC, mapping and gene counting were done
with  zUMIs126.  If  needed,  the  FASTQ  files  were  also  demultiplexed  using  JE
Demultiplexer127. FASTQC128 was used for quality control. STAR129 aligner was used for
mapping and gene counting. 
3.3.2 Data Analysis and Visualization
Statistical  analysis  and  visualization  were  done  in  R130 using  the  RStudio131 app  for
Windows and Linux environment: 
For single-cell analysis Seurat132 v4.0 package was followed whenever possible. 
For bulk sequencing data analysis, DEseq2133 package was used. 
Most of the visualization was done using ggplot2134, and its accompanying suites. 
Bioconductor135 open  source  project  was  used  to  manage  the  host  of  packages  and
programs used in R.
1. All R scripts used are available at: https://github.com/kgunnar-lmu/PhD-Thesis
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4  Establishing RNA sequencing and barcoding based on 
SCRB-seq
4.1 Introduction
Single-cell sequencing technology has progressed rapidly since its inception. Currently,
there are dozens of different methods and hundreds of protocols about capturing, lysing,
and preparing single-cell libraries. In more practical terms, the main pipelines fall primarily
into  two  major  categories:  droplet-based  cell-capture  and  preparation  methods  use
microfluidic chips and oligo-coated beads like Drop-Seq28 and Chromium system from 10x
Genomics136 and microwell plate-based (or just plate-based) platforms that usually require
flow cytometry for cell sorting and capture. Plate-based methods offer higher flexibility and
have a larger variety of protocols for each step, from the initial cell capture to the final
sequencing ready library. 
4.1.1 Development of plate-based single-cell sequencing methods
In 2012, a few years after the first single-cell RNA-seq paper was published, Smart-seq 33
laid the groundwork for many plate-based methods. It was subsequently updated in 2014
with  the  addition  of  Smart-seq  234 and  in  2020 with  Smart-seq  335.  The  SMART-seq
protocol  is  an unofficial  standard in  the single-cell  sequencing world,  and it  has been
shown  to  have  the  highest  sensitivity  and  power  (the  probability  of  detecting  an
effect)137,138. However, one major flaw is the requirement of significant hands-on time, and
due to  the handling of  each cell  individually  until  the last  step also rather  costly.  The
solution to simplify this process was to “tag” or attach a known sequence (a barcode) to
each cDNA molecule during  RT or amplification, after which one could pool all the cells
together and proceed with far fewer samples32. One major drawback of this kind of pooling
is that it is no longer possible to get full-length transcript sequences as the barcode will be
in either or both ends (3’-5’) of the molecule, and after the fragmentation, only the cDNA
fragments with barcode are useful  and selected for sequencing. Thus, we end up with
counts of genes or digital gene expression.
Another significant change, especially for single-cell sequencing, was the introduction of
counting of absolute numbers of molecules with the aid of Unique Molecular Identifiers or
UMIs for short139.  UMI, like a barcode, is a short (usually between 10-20) sequence of
randomized bases and is attached to the oligo(dT) primer. After RT, each cDNA fragment
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will  contain  a  UMI  sequence  and  makes  a  one-of-a-kind  combination  of  UMI  and
sequence. After the PCR, if some sequences are amplified more readily than others, it is
possible  to  identify  them.  During  the  analysis  and  mapping,  these  sequences  are
collapsed, so every UMI-sequence pair is only represented once. UMIs allow accurate
identification of PCR duplicates, which is especially relevant for single-cell libraries where
the capture efficiency of mRNA molecules and amplification bias can vary considerably
even within the same experiment.
Figure 4.1.1 SCRB-seq protocol overview. 1. Cells are sorted into microwell plates using flow cytometry. 2.
cells are lysed in a hypotonic solution in the presence of barcoded oligos, dNTPs, and RNAse inhibitors. 3.
after lysis, an RT master mix is added to each well. 4. all samples are pooled, cleaned up, and concentrated
using SPRI beads. 5. single-primer PCR amplification produces full-length, barcoded cDNA. Figure adapted
from48.
One protocol that incorporates all those advances is the Single-Cell RNA Barcoding and
sequencing or SCRB-seq. SCRB-seq is an affordable and easily scalable 3’ digital gene
expression RNA sequencing protocol that allows simultaneous sequencing of thousands of
cells. It is sensitive and simple to set up. Cells are captured into a microwell plate using
flow cytometry. This allows for the use of extracellular markers for additional information
about the cells, also called index sorting. This information is saved and can be used later
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in  conjunction  with  the  sequencing  data.  After  sorting,  cells  are  lysed,  and  mRNA is
captured  and  reverse  transcribed  using  barcoded  oligo(dT)  primers.  Once  barcoded,
cDNA can be pooled, cleaned up, and amplified, after which the samples are ready for
library preparation and sequencing (Fig. 4.1.1).
Another valuable property of SCRB-seq is the possibility to use the same protocol with
low-input bulk samples (~50 000 cells). With low-input bulk input, the protocol has much
increased sensitivity.  It  is  a lot  cheaper than regular bulk-seq sample preparation, and
because of the multiplexing, it is possible to prepare hundreds of samples at the same
time. The single-cell resolution is lost, and only a basic gene expression profile can be
acquired (no alternative splicing, SNPs, or RNA editing can be detected), but it can be
helpful for screening purposes or for samples that are difficult or expensive to acquire. 
4.1.2 Innate immune system and PRR signaling
Our immune system is comprised of two main arms: innate and acquired immunity.  The
innate  immune  system  acts  as  the  first  line  of  defense  against  exogenous  and
endogenous threats, such as infection, tissue damage, and cancer. It  also functions to
instruct and orchestrate adaptive immune system responses. Innate immune responses
have been found in all kingdoms of life, and in many cases, the general principles that
regulate innate immunity are conserved between species. Innate immune responses are
not specific to a particular pathogen; instead, they rely on receptors that have evolved to
detect  unchanging  structures  in microbial pathogens, commonly referred to as microbe-
associated molecular patterns (MAMPs). For those, there are dedicated receptors in the
host called pattern recognition receptors (PRRs)6. 
In  mammals,  the  PRRs  can  be  broadly  separated  into  extracellular  and  intracellular
sensors. One major group of extracellular PRRs are the proteins belonging to the Toll-like
receptor  family  (TLR).  TLRs are transmembrane receptors,  and as such,  they sample
MAMPs  in  the  extracellular  space.  A prominent  member  of  this  family  is  TLR4  that
recognizes lipopolysaccharide (LPS),  a  common cell  wall  component  of  gram-negative
bacteria6. 
LPS signaling occurs through many interactions. First, it is  sensed by TLR4 and its co-
receptor MD2. This triggers downstream signaling cascades. TLR4 is unique in the TLR
family  as  it  can  use  all  the  known  Toll-interleukin-1  receptor  (TIR)  domain-containing
adaptor  proteins.  This  TLR4  activation  results  in  two  separate  signaling  pathways
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(Fig.4.1.2 A): myeloid differentiation primary response gene 88 (MYD88) dependent and
independent pathway. MYD88 dependent pathway leads to a fast cytokine signaling to
alert and activate lymphocytes, also known as the NF-κB pathway140,141. 
The  MYD88  independent  pathway  leads  to  the  type  I  interferon  response  through
interferon regulatory factor 3 (IRF3). This response tends to be slower and helps to trigger
antimicrobial  programs  to  limit  the  spread  of  the  infection  and  modulate  the  immune
responses and restrain cytokine production141,142. 
Figure 4.1.2  The TLR4 and cGAS-STING signaling  pathways.  TLR4 receptor  senses LPS and triggers
MYD88 dependent  and independent  signaling leading to  proinflammatory cytokine signaling and Type I
interferon response. cGAS senses dsDNA in the cytosol and triggers the cGAS-STING signaling pathway
resulting in Type I interferon response. 
There are many genes that get upregulated directly by NF-κB. Genes such as Ccl2, Ccl3,
Ccl4, Ccl5, Cxcl1, Cxcl2, Cxcl5,  Cxcl10, Ccrl2  induce leukocyte recruitment while Hdc,
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Nos2, Ptges, Ptgs2 are inflammatory mediators. Also, some inflammatory cytokines like Il-
1α, Il-1β,  Il-6, Il-18, Tnf, and anti-viral  Ifn-Β have increased  transcription143.  NF-κB also
limits the inflammatory response by upregulating genes, such as Tnfaip3, and Nfkbia that
inhibit  TLR4  signaling  in  order  to  protect  the  host  from  tissue  damage  by  excessive
inflammation. 
Intracellular PRRs can also recognize pathogens via MAMP molecules. In addition, some
intracellular PRRs can also sense endogenous molecules when they have translocated
into a wrong compartment in the context of cell damage. One such sensor is Cyclic GMP-
AMP Synthase (cGAS) that detects cytosolic double-stranded DNA (dsDNA). Activation of
cGAS leads to the production of cyclic GMP–AMP (cGAMP), which in turn triggers the
Stimulator  of  INterferon  Genes  (STING)  and  leads  to  the  type  I  interferon  response
through IRF3  (Fig.4.1.2 B)144,145.  This cGAS–STING pathway induces several  interferon
signaling  genes  (ISGs)  that  help  prevent  the  replication,  assembly,  and  release  of
viruses142. 
4.2 Overview 
As discussed above, the SCRB-seq protocol was already established, but it was optimized
for 384-well plates. To avoid the massive upfront cost of 384 barcoded primers, we initially
opted to set up SCRB-seq in our lab for 96-well  format. Also, during the setup, a few
improvements to the method were published48, and we decided to test those in our setup. 
To show the capabilities of the new and improved SCRB-seq, we prepared libraries  and
sequenced more than 300 macrophage-like differentiated BLaER1 cells. We also used the
SCRB-seq  protocol  to  prepare  and  sequence 168  low-input  bulk  samples  of  different
knockouts (KOs) of innate immune system regulators and IκB kinases. 
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4.3 Results
4.3.1 Original SCRB-seq protocol yields low amounts of cDNA and has poor 
sequencing results
The SCRB-seq protocol was initially designed to work with a 384-well plate format with 2
μl total RT reaction volume per well. While trying to establish the protocol, we decided to
opt for  a 96-well format to save on the initial investment cost by ordering only a quarter
(96) of high purity barcoded oligo(dT) primers (TruGrade® DNA Oligo from IDT). Yet, the
initial  results  from  SCRB-seq  were  not  promising.  We  prepared  four  plates  of
transdifferentiated  BLaER1  macrophages  stimulated  with  LPS  for  two  hours  or  left
unstimulated as a control. As determined by Quant-iT PicoGreen dsDNA Assay, the final
concentration of cDNA libraries, after pre-amplification, was less than 1 ng/μl,  and the
Bioanalyzer (Agilent 1000 DNA chip) detected only low amounts of cDNA or none at all
(Fig.4.3.1 A). The most promising sample was subjected to sequencing, which resulted in
a  very  low  sequencing  quality.  Out  of  more  than  100  million  reads,  only  3.6% were
uniquely mapped to the human genome, with a median of 535 genes detected per cell,
most of which were mitochondrial reads (Fig.4.3.1 B). 
Figure 4.3.1 (A)  Two plates of scRNA-seq libraries prepared using SCRB-seq protocol.  Bioanalyzer traces
show the libraries after Nextera tagmentation and PCR. The amount of DNA translates to intensities depicted
by Fluorescent Units (FU) on the y-axis. The size of DNA fragments is given in base pairs on the x-axis. The
expected peak should be around 400-600 bp, but only on the second panel, a small accumulation of rather
long DNA fragments are detectable. (B) zUMIs pipeline’s statistical output of one plate (94) of single cells. In
the top panel, the average number of detected genes in the whole library, based on where in the gene body
they mapped to. In the bottom panel, the total number of reads in the library on the left and a percentage of
uniquely mapped reads on the right. A gray area indicates unmapped reads.
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4.3.2 Changes to SCRB-seq lysis buffer and increased volume of RT reaction 
increase cDNA yield in 96-well plate format
To optimize the SCRB-seq protocol to suit our needs better, we tried several modifications
that have been described to increase the cDNA yield34,48. To make up for the larger wells,
we increased the RT reaction volume to 10 μl.  This lowered the concentration of enzymes
in a given reaction, but the total amount used remained the same. Indeed, increasing the
reaction volume had a significant, positive effect on cDNA synthesis, as indicated by the
PicoGreen assay (Fig. 4.3.2 A).  
After  establishing  a  reliably  working  protocol,  we  introduced  additional  modifications.
Oligo(dT)  barcoded primers  were  redesigned to  extend the  barcode from six  to  eight
nucleotides to assist with correct barcode assignment and increase the hamming distance
to 1, which means that the new barcodes can now handle a single mutation/error and still
be correctly assigned. Before ordering new barcoded primers, a single primer was ordered
from IDT (HPLC quality)  to  produce  test  libraries.  No  difference  was  found  in  cDNA
synthesis  efficiency between the original  SCRB-seq primer  and the extended barcode
primer (Fig.4.3.2 B).
As Smart-seq234 was the most  sensitive137 single-cell  sequencing protocol,  we tried to
modify  our  protocol  by  following  its lysis and RT  steps.  For  RT, both Smart-seq2 and
another  popular  protocol,  MARS-seq31,  use  the  SuperScript  Reverse  Transcriptase
(Thermo Fisher Scientific). We compared it  to the original  SCRB-seq  Maxima H Minus
Reverse Transcriptase (Thermo Fisher Scientific). While both enzymes yielded  sufficient
cDNA, it  was  clear that Maxima H-  was more efficient, especially for lower amounts of
input RNA (Fig.4.3.2 C).
The final change to the original protocol was to modify the lysis buffer. We decided to use
a  hypotonic  lysis  buffer  containing  0.2%  Triton  X-100,  thermostable  ribonuclease
inhibitors, dNTPs, and barcoded oligo(dT) primers. We opted to skip the Proteinase K
digest,  heat  inactivation,  and  RNA  desiccation  (post  lysis).  This  increased  average
fragment length, as high temperatures, even for a short time, have been shown to degrade
RNA, especially in the presence of metal ions (found in many buffers)146,147. Also, by using
thermostable ribonuclease inhibitors, the mRNA was protected from the cell-capture stage
until the pooling. Having the barcoded primers already in the lysis buffer streamlined the
workflow by reducing the handling time necessary for pipetting. Including dNTPs following
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lysis  has  shown  to  be  beneficial  for  cDNA synthesis148.  The  new  lysis  buffer  did  not
increase  the  yield,  but  it  produced  more  intact  cDNA fragments,  as  seen  from  the
Bioanalyzer traces (Fig.4.3.3 A and C).
Figure  4.3.2  Quant-iT™ PicoGreen™ dsDNA Assay.  All  libraries  were  quantified  after  pre-amplification.
Shown as dots are the cDNA yields of independent experiments. The input used in an experiment is given on
the x-axis, either UHRR, BLaER1 cells, or no input –  Neg.Ctrl. Gray area indicates the 95% confidence
interval, solid line shows the locally estimated scatterplot smoothing or LOESS curve. (A) Original SCRB-seq
(v.1) compared to increased lysis and RT reaction volume protocol (SCRB-seq v.2). PCR Neg. – a negative
control  from  pre-amplification  step  onward.  (B)  Original  (old)  primer  compared  to  extended  barcode
sequence  primer  (new).  (C)  Comparison  of  two  different  RT  enzymes.  SSIV  –  SuperScript  IV.  (D)
Comparison of improved SCRB-seq (v.3) and mcSCRB-seq protocols.
4.3.3 mcSCRB-seq does not improve cDNA quantity nor quality
Around  the  time we  were  setting  up SCRB-seq,  a  study  was  published  showing that
adding PEG (polyethylene glycol) 8000 to the RT reaction increases cDNA synthesis and
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increasing the overall  sensitivity (RNA capture efficiency)  of  the sequencing.  This  new
protocol  was also based on SCRB-seq and is  called mcSCRB-seq48.  We followed the
instructions  described  in  the  paper  but  the  benefits  of  adding  PEG  (7.5%  end
concentration) to an RT mixture were not immediately obvious. At certain concentrations,
mcSCRB-seq seemed to increase cDNA yield, but not in a significant way (Fig.4.3.2 D).
When analyzing the mcSCRB-seq libraries with the Bioanalyzer, we discovered that, on
average, the fragment lengths were shorter than SCRB-seq v.3 libraries (Fig.4.3.3). 
Figure 4.3.3 Bioanalyzer traces. (A) A library produced from 100pg UHRR input using SCRB-seq v.3. (B) A
library produced from 100pg UHRR input  using the mcSCRB-seq protocol. (C) A library produced from 32
single cells,  pooled  before pre-amplification,  SCRB-seq  v.3.  (D)  A library produced from 32 single cells,
pooled before pre-amplification, SCRB-seq v.2.  X̅ - average fragment length of samples.
4.3.4 Improved SCRB-seq outperforms the original and mcSCRB-seq protocols
To  measure  if  the  alterations  to  the  SCRB-seq  protocol  translated  into  improved
sequencing in a biologically relevant experiment, we stimulated BlaER1 macrophages with
LPS  followed  by  sequencing  and  analysis.  We  transdifferentiated  BLaER1  cells  into
macrophages, stimulated them with LPS, and harvested the cells for sorting and library
preparation. We sorted four 96-well plates: one plate to be prepared using SCRB-seq v.2,
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two  plates  to  be  prepared  using  SCRB-seq  v.3,  and  one  plate  to  be  prepared  using
mcSCRB-seq.
Figure 4.3.4.  (A) zUMIs pipeline statistical output. The total number reads in each library of 94 cells on the
left side. Percentage of uniquely mapped reads on the right. (B) scRNA-seq data of four different libraries
and three different methods. Index sorting information was used for color overlay in the UMAP plots (based
on top 100 HVGs) showing, how well sequencing data captures the effects of LPS stimulation. Numbers on
each plot show how many cells out of the 94 were detected and passed the QC and filtering. 
After sequencing, we used zUMIs pipline126 to perform demultiplexing, mapping, feature
counting, and quality control (QC) statistics. The two plates prepared using SCRB-seq v.3
had the highest uniquely mapped read percentage, which we took as a sign that those
libraries were of good quality. It has been shown that uniquely mapped reads or reads that
map to only one location within the reference genome indicate higher quality RNA-seq
data25. Another indicator of library quality is the percentage of exonic reads, where a low
percentage  of  exonic  reads  can  indicate  RNA degradation  or  DNA contamination149.
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Library prepared using mcSCRB-seq performed the worst in regards to uniquely mapped
reads and the percentage of exonic reads. The library derived from the original SCRB-seq
protocol  with  higher  reaction  volumes  and  no  evaporation  step  performed  marginally
worse than SCRB-seq v.3 method (Fig. 4.3.4 A). 
Since LPS is a well-studied stimulus, and we had the index sorting information (additional
information to verify the accuracy of clustering), we could use the simple clustering of cells
based on the stimulation as an indicator of sequencing quality. As expected, we saw a
clear separation of cells based on the LPS treatment in all libraries prepared using SCRB-
seq improved protocol  (Fig.  4.3.4 B).  For  the mcSCRB-seq library,  no clear  treatment
effect was evident. When we looked for differentially expressed (DE) genes, no hits were
found, below the false discovery rate (FDR) of 0.05 or lower (data not shown). 
All  of  the  changes introduced into  the  SCRB-seq protocol  helped produce cDNA with
higher quality and quantity, and it works equally well for control RNA input (UHRR) as well
as for living cells.  Our improved SCRB-seq protocol has the highest uniquely mapped
reads and exonic reads percentages and the lowest cell dropout level.
4.3.5 Improved SCRB-seq reveals a robust inflammatory response after LPS 
stimulation in BLaER1 cells
To  better  analyze  our  data  and  to  increase  the  statistical  power,  we  integrated the
remaining three successful datasets. As the differences between them are expected to be
caused  mainly  by  technical  noise,  we  used  the  scTransform  function  in  the  Seurat
package  to  normalize,  scale,  and  remove  confounding  sources  of  variation.  As
confounding variables, we chose library size (total UMIs per cell) and plates (SCRB-seq
v.2,SCRB-seq v.3 p1 and SCRB-seq v.3 p2). The last two datasets, plate one and plate
two,  mixed  together  well  even  without  batch  correction  (data  not  shown).  This  was
expected as they were sequenced on the same flow cell. The first dataset stood apart from
the  rest  initially,  but  when  regressing  out  confounding  variables,  cells  from  all  three
datasets made two distinct clusters. The upper  population almost exclusively contained
LPS stimulated cells, while the lower one was made up of all the unstimulated cells plus
some stimulated  cells.  It  is  conceivable  that  these  cells  either  failed  to  respond  to  a
stimulus or that there was a carry-over during cell sorting, as the unstimulated cells were
always sorted first (Fig. 4.3.5 A).  
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We can again overlay the UMAP plot with the cell sorter index information, and it becomes
clear that biological effect dictates the clustering of cells. We also noticed that a few cells
from the stimulated group locate to the unstimulated group. For this reason and because
the index sort information may not always be available, we ran Louvain clustering to find
subsets in our data in an unbiased way. Resulting clustering largely agrees with indexed
sort information, where Louvain group 1 is composed of LPS stimulated cells and group 2
is unstimulated cells and cells that did not react to the stimulus (Fig. 4.3.5 A).
Figure 4.3.5 (A) UMAP plots (based on top 3000 HVGs)  on three integrated datasets. From left to right:
different datasets as seen in Figure 4.3.4.A, cell sorter index information, unsupervised Louvain clustering.
(B) Volcano plot showing DE results between Louvain cluster 1 and 2. (C) Pathway enrichment analysis
based on all significantly upregulated genes (FDR<1%).
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To find out  what effect  LPS stimulation has on BLaER1 cells and to further  show the
capabilities of improved SCRB-seq protocol, we conducted DE analysis  between these
clusters. Doing so revealed a robust upregulation in several proinflammatory cytokines like
IL-1B, CXCL8 (IL-8), IL-6, and chemokines like CCL4 and CCL3 (Fig.4.3.5 B). 
As a final approach to validate our findings thus far, we performed pathway enrichment
analysis using the PANTHER Pathway tool150 on all genes significantly upregulated in the
1st cluster  with  FDR less  than  1%.  The  analysis  revealed  a  significant  enrichment  of
pathways related to cytokine signaling and response, inflammatory response, and defense
response (Fig.4.3.5 C).
4.3.6 Low-input bulk sequencing using SCRB-seq protocol enables low-cost 
transcriptome profiling of hundreds of samples
Another application for SCRB-seq is low-input bulk sequencing. In regular sequencing, the
library  preparation  is  performed  on  millions  to  tens  of  millions  of  cells,  resulting  in
micrograms on input RNA, whereas low-input bulk sequencing using SCRB-seq protocol
would allow anything from a single-cell to tens of thousands of cells to be used as input
(picograms to nanograms of RNA). 
The main difference between low-input bulk and single-cell SCRB-seq is the need for RNA
isolation. For single cells, the lysis reaction volume is many orders of magnitude greater
than any given cell. Thus, there is no need for RNA isolation and purification (also no need
to remove genomic DNA), but with many thousands of cells, the cellular debris, as well as
leftover culture media, can interfere with the RT reaction. For this reason, the SCRB-seq
v.3 protocol was supplemented with SPRI bead RNA clean-up and with DNAse I digest to
remove genomic DNA (gDNA).
After initial testing, we found the optimal input of cells to be around 50,000. This number of
cells  was required to  overcome small  variations caused by cell  counting and pipetting
errors while not inhibiting downstream sample preparations, including bead-based clean-
up in a 96-well format. Higher numbers of cells would also require the RNA clean-up to be
performed  in a separate vessel. We also observed that 50,000 cells combined with the
single-cell  reaction  mix  (matched  enzyme  concentrations,  RT,  and  pre-amplification
reaction volumes) to be most optimal for cDNA synthesis and amplification (Fig. 4.3.6 A).
To verify this, we prepared four libraries, two with 50,000 and two with 2 million cells, and
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proceeded with the library preparation until the end of the pre-amplification step. We then
used the Bioanalyzer read-out to assess the quality of libraries. As seen in Figure 4.3.6 B,
increasing  the  cell  number  had no observable  benefit,  but  instead,  there  was a  clear
increase in primer-dimers around 500 bp, as shown by the strong peak in the Bioanalyzer
trace.  We, therefore, decided to proceed with 50,000 cells per sample for low-input bulk
sequencing. 
Figure 4.3.6 (A) Quant-iT™ PicoGreen™ dsDNA Assay. cDNA concentration measured after 20 cycles of
pre-amplification  for  differing  numbers  of  input  cells  (BLaER1).  Each  dot  represents  an  independent
experiment (library). Gray area indicates the 95% confidence interval, solid line shows the locally estimated
scatterplot smoothing or LOESS curve. (B) Bioanalyzer traces of 2 representative samples. All libraries were
treated the same, only differing in the input amount. (C) Uniquely mapping read percentage depending on
the read length depicted as mean +/- SEM of three independent libraries.
As sequencing costs can be prohibitively high, we attempted to find the most cost-effective
sequencing length for the cDNA reads. We subjected our samples to 18 bp + 100 bp
paired-end sequencing on the Illumina 1500 HiSeq machine. The reads were trimmed to 3
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sets of differing read-lengths: 50 bp, 75 bp, and 100 bp. Data from these three sets were
processed with zUMIs126.  As SCRB-seq is effectively a single-end sequencing method,
longer reads will increase mapping efficiency. We saw that 75 bp read length was the most
cost-effective approach resulting in 10% more or 79,6% uniquely mapped reads compared
to the 50 bp reads, and 100 bp long reads showed diminishing returns by only improving a
few percentage points  (82.1%)  (Fig.4.3.6  C).  With  the  protocol  optimized to  maximize
output while limiting cost and handling, we applied the protocol as a proof of principle
using a heavily studied pathway in our laboratory.
4.3.7 Low-input bulk-seq reveals Type-I interferon and proinflammatory cytokine 
signaling pathways in BLaER1 macrophages after PRR stimulation
We employed the optimized low-input bulk SCRB-seq to elucidate the roles of kinases of
the IKK family (IκB kinase) in the cGAS-STING and TLR4 signaling pathway. Our goal was
to identify transcripts that show a clear NF-κB or Interferon regulatory factor (IRF) signal in
a knockout-dependent manner. To this end, we prepared 168 samples comprising of WT
cells, as well as single, double, and quadruple knockouts with two different stimulation
conditions  (see  table  4.3.7).  The  LPS  stimulation  was  chosen  for  its  strong  NF-κB
induction via the TLR4 signaling pathway,  while dsDNA stimulation was chosen for its
ability  to  induce  interferon  signaling  through  the  cGAS/STING  pathway.  Cells  were
stimulated with LPS (2 ng/mL) or transfected with HT-DNA (200 ng/well) for 2 hours, and
subsequently, the cells were harvested for RNA-Seq analysis.
Table 4.3.7 Bulk RNA-sequencing sample table. Listed are all the genotypes used for this experiment. In the
cells under each stimulation condition,  the first number indicates how many samples  per  genotype  were
prepared,  separated  by  backslash  the  second  number  indicates  how  many  remained  after  QC  and
subsequently used in the analysis.
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Stimulation
Genotype dsDNA 2h LPS 2h Unstimulated Total
1 4/4 4/3 4/4 11
2 4/3 4/4 4/4 11
3 4/4 4/4 4/4 12
4 4/3 4/4 4/4 11
5 4/4 4/4 4/3 11
6 4/4 4/4 4/2 10
7 4/4 4/4 4/4 12
8 4/4 4/4 4/3 11
9 4/4 4/4 4/4 12
10 4/2 4/2 4/2 6
11 4/4 4/4 4/4 12
12 4/3 4/2 4/2 7
13 WT 8/8 8/8 8/8 24










TBK1-/- x IKBKE-/- x CHUCK-/- x IKBKB-/-
TICAM1-/-
TICAM1-/- x MYD88-/-
After sequencing, we used zUMIs to demultiplex, map, and count features. We continued
the analysis  by  following the  standard  Seurat  workflow to  effectively  handle  the large
number of samples. We first analyzed the clustering within our dataset. Both the graph-
based  clustering  (Louvain  Fig.4.3.7.  A)  and  hierarchical  clustering  (based  on  top  500
HVGs Fig.4.3.7.  B) revealed three main clusters, reflecting the effects of different stimuli
and genetic knockouts on gene expression. The clusters are distinguished based on their
stimulations: dsDNA in red, LPS in blue, and mixed samples in green. The latter group is
mainly  composed of  unstimulated cells,  or  cells,  in  which  key signaling  pathways are
disrupted due to genetic perturbations (Fig. 4.3.7 A).
Figure 4.3.7  (A)  PCA (based on top 1000 HVGs)  plot  showing 168 samples.  Colors  of  samples show
stimulation: LPS, dsDNA, or unstimulated. The colors of lines indicate three clusters found by the Louvain
algorithm, which we conditionally called LPS cluster (blue), dsDNA cluster (red), and unstimulated cluster
(green). Samples that are stimulated but have their essential pathways perturbed cluster with unstimulated
samples.
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Samples in the red cluster (dsDNA stimulated) exhibit a robust interferon signature that is
abolished in IRF3-/- x IRF7-/- and TBK1-/- x IKBKE-/- double and TBK1-/-  x IKBKE-/- x CHUCK-/-
x  IKBKB-/- quadruple  knockouts (Fig.  4.3.7  A and  B).  cGAS-STING  signaling  mostly
triggers  the  interferon  response  and  shows  only  a  relatively  weak  NF-κB  dependent
cytokine response. 
Figure 4.3.7. (B) Clustered heatmap based on top 100 HVGs. Both samples (columns) and genes (rows) are
hierarchically clustered based on euclidean distance.  Gene expression values averaged across replicates
were used to build this heatmap. Based on the dendrogram, three main groups of samples are indicated by
splitting the heatmap. Colored bars indicate treatment: dsDNA (red), LPS (blue), and unstimulated (green). 
As expected, the blue cluster (LPS stimulation) exhibits a strong NF-κB dependent gene
expression profile due to activation of the TLR4 receptor by LPS, however, in contrast to
previously published work, we observed an unusually low interferon response. Despite
this, we found several ISGs that showed a moderate up-regulation after two hours of LPS
stimulation  in  NF-κB  dependent  manner,  such  as  CXCL10 (IP10),  MX2,  and  CCL8.
Conversely, other well-known ISGs like IFIT1, IFIT2, MX1, and ISG15 showed a clear NF-
κB independent  expression profile.  In  addition,  we  also  found several  less well-known
ISGs that were upregulated in a dsDNA-specific manner only, such as  OASL, EPSTI1,
and HERC6 (Fig. 4.3.7 C). The TLR4 dependent induction of transcripts was interrupted in
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RELA-/- and  MYD88-/- x  TICAM1-/- double  knockouts while  remaining  functional  in  both
MYD88-/- and TICAM1-/- single knockouts (Fig. 4.3.7 A and B). 
The  NF-κB  pathway  is  also  activated,  albeit  to  a  lesser  degree,  following  dsDNA
stimulation.  Many highly  expressed genes in  the NF-κB regulated cluster  also show a
slight  upregulation following dsDNA stimulation, for example,  CCL4L2,  CCL4, and  IL-1B
(Fig. 4.3.7 C). 
In  addition  to  observing  the  well-known  elements  of  these  two  pathways,  our  data
indicated that two main kinases are required for each signaling pathway. TBK1 and IKBKE
for the interferon pathway and  CHUCK and  IKBKB for the  NF-κB pathway. When either
pair was knocked out, it caused samples to cluster with unstimulated samples. Additionally,
we observed that both of these pairs of kinases are redundant in their function for the two
signaling pathways, meaning that a single knockout of either will not be enough to halt the
signaling cascade. In other words, only when TBK1 and IKBKE were depleted, a complete
termination of antiviral gene expression was seen in the cGAS-STING signaling pathway.
On the other hand,  samples in which both kinases of the canonical IKK complex were
knocked  out (CHUCK (IKKα)  and  IKBKB  (IKKβ))  had  a  completely  interrupted  TLR4
response and thus clustered together with the unstimulated cells. As expected, TBK1 and
IKBKE are only required for interferon signaling and have no role in the NF-κB pathway. 
Similarly,  CHUCK  and  IKBKB  are  redundant  in  their  function  for  the  NF-κB signaling
pathway and do not affect interferon signaling (Fig. 4.3.7 C). We also noticed that NF-κB
signaling  was  reduced  in  both  MYD88  and  TICAM1  knockouts  but  not  completely
abolished.  Only  in  double-knockout  samples  of  MYD88  and  TICAM1 did  we  observe
complete  signaling  ablation  in  gene  expression  (Fig.4.3.7.  C)  and  sample  clustering
(Fig.4.3.7. A).
Another  interesting  notion  from  these  studies  is  that  the  low  but  consistent  NF-kB
response observed downstream the cGAS-STING signaling pathway was also dependent
on the  canonical  IKKs;  CHUCK and  IKBKB.  Also,  here,  both  kinases appeared to  be
redundant since only the deletion of both kinases displayed a full effect. However, in light
of the rather weak NF-kB response observed under these conditions, additional studies
are required to confirm these results.
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Figure 4.3.7. (C) Zoomed-in version of Figure 4.3.7.B heatmap. Shown are the three major gene expression
modules, an NF-κB dependent module, and two IRF dependent modules. On the left:  dsDNA stimulated
samples. On the right: LPS stimulated samples. 
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4.4 Discussion
4.4.1 Single-cell RNA barcoding and sequencing
Single-cell RNA sequencing (scRNA-seq) has become increasingly more popular in recent
years26. It has rapidly changed since the first single cells were sequenced by Tang et al. in
2009. A multitude of varying methods is now available that significantly differ in sensitivity
and throughput137,151. To increase flexibility, reduce cost and throughput, we decided to set
up a plate-based method compatible with flow cytometry. We chose SCRB-seq, a method
with minimal setup requirements and low upfront cost that is easily expandable if higher
throughput is required30. 
The  original  SCRB-seq  protocol  was  described  using  384-well  microwell  plates  and
included an RNA desiccation step after Proteinase K digest to remove the lysis buffer and
heat-inactivate the enzymes.  This was done to keep the RT reaction volumes as low as
possible (2 μl per sample). These steps were not optimal for our setup as the low reaction
volumes in increased well size caused unwanted evaporation, and through that, variation
in  RT  efficiency.  The original  protocol  also  included a desiccation step right  after  lysis
(which we omitted) as it seemed to be too damaging to the RNA.
Following the lysis buffer's optimization, omitting RNA desiccation, and increasing the RT
volume, we observed significant improvements in our libraries’ quality, both before and
after sequencing (Fig.4.3.4 and 4.3.3). We attempted to improve our protocol even further
using a newer reverse transcriptase, SuperScript IV (Life Technologies), that is used in
many protocols34,136,148; unexpectedly, it did not provide any marked increase in the cDNA
yield. This could be due to SuperScript IV being designed for speed and resistance against
inhibitors and RNAse activity–all beneficial traits –but unnecessary in our situation. Also,
Zucha et al. and Bagnoli et al. have shown that the Maxima H- reverse transcriptase’s
(used in our protocol) sensitivity is as good or better than SuperScrpit IV48,152.
While we were setting up and testing our improved SCRB-seq protocol, another group
published  their  own  improvements  to  the  same  original  method,  which  they  called
mcSCRB-seq. Our improved SCRB-seq and mcSCRB-seq protocols only differ in the lysis
and RT steps. mcSCRB-seq still uses Proteinase K digest while omitting RNA desiccation
in favor of  heat  inactivation.  It  incorporates polyethylene glycol  (PEG) 8000 in  the RT
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reaction  to  achieve  the  molecular  crowding  effect.  It  has  been  shown  that  adding
macromolecules  increases  enzymatic  activity,  possibly  due  to  a  reduction  in  effective
reaction volume153. Bagnoli et al. displayed that this effect also increases the efficiency of
scRNA-seq  library  preparation,  but  they  used  standardized  input  (UHRR)  and  mouse
embryonic stem cell lines in their assessment while not considering very small cells with
very  low RNA concentration.  In  our  hands,  using  mcSCRB-seq  to  sequence BLaER1
macrophages,  failed  to  produce  good  quality  libraries;  we saw  much  more  inferior
sequencing results than with SCRB-seq v.3. The results contained more unmapped reads,
a lower percentage of exonic reads, and cells failed to segregate based on the stimulus
(Fig. 4.3.4 B). This could be because BLaER1 cells in their B cell and macrophage stage
are rather small and contain relatively small amounts of RNA154. Hagemann-Jensen et al.
found that B cells, along with T cells, are among the most challenging cells to capture in
scRNA-seq35. 
Similar to the authors of the mcSCRB-seq paper, we also noted that increasing the PEG
8000 concentration above a certain threshold leads to unspecific amplification48, which in
our case, interfered with sequencing results (Fig. 4.3.4 A). Although we did not increase
the PEG concentration over the recommended threshold, the amount of available template
per reaction was much lower due to the cell type used.
We also noted a shorter average fragment length of mcSCRB-seq libraries, partly because
of the increased unspecific amplification. It could also have been due to differences in the
lysis step as mcSCRB-seq still incorporates Proteinase K digestion and heat inactivation.
We noticed similarly shortened fragments in our SCRB-seq test where we had not yet
optimized  the  lysis  buffer.  Proteinase  K  digest  seems  like  a  sound  option  to  rid  the
samples of  RNases,  but  the same can be achieved with  adding RNase inhibitors.  By
skipping the digest, we save time and protect the samples from high temperatures (heat
inactivation of Proteinase K).
Our improved SCRB-seq outperformed the original protocol. The libraries had high-quality
cDNA as  assessed  by  the  Bioanalyzer,  and  the  sequencing  results  displayed  a  high
percentage of exonic reads while maintaining a low dropout rate. This success was also
observed  when  applying  our  protocol  to  a  relevant  biological  setting  in  BlaER1
macrophages stimulated with LPS. As already mentioned, we did not manage to produce
the  same high-quality  libraries  using  the  mcSCRB-seq  protocol.  Cells  prepared  using
mcSCRB-seq did not show gene expression changes in an LPS dependent manner. From
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the rest of the libraries, we found a robust inflammatory signal (Fig. 4.3.5). We were also
able to integrate all  the remaining libraries into a single experiment,  thus showing that
experiments from different sequencing runs can be combined155. Combining experiments
increases the statistical power156 and allows us to detect lowly expressed transcripts. 
4.4.2 Low-input bulk RNA sequencing and barcoding
As the SCRB-seq protocol  is entirely compatible with larger input of cells, we thought to
test it as a low-input bulk RNA-seq method. This type of bulk RNA sequencing has many
benefits.  It  allows for much higher throughput than regular bulk sequencing. Preparing
dozens or even hundreds of samples in this fashion is no more difficult than preparing a
single sample. This protocol controls PCR amplification bias due to early barcoding (UMIs
on oligo(dT) primers)157. Because of pooling, it is also much more affordable than regular
bulk  RNA-seq.  The wet-lab cost  of  a  single low-input  bulk  sequencing sample is  only
marginally higher than for one cell in SCRB-seq protocol (the difference comes from RNA
isolation/clean-up).  The  only  real  difference  compared  to  scRNA-seq  comes  from the
sequencing depth. For single cells, the most cost-effective sequencing depth seems to be
between 20 000 – 200 000 reads29,35,156,  but  for  bulk  samples,  we could  increase the
sequencing depth up to a few million before saturation is reached. It is, of course, highly
cell  type-dependent,  and  test  sequencing  runs  should  be  performed.  Recommended
sequencing depth would also depend on the aim of the project. For screening purposes,
fewer reads would suffice. 
The drawbacks of this bulk sequencing are the same as they are for SCRB-seq. Because
of the protocol’s setup, we end up with only 3’ ends of transcripts. This is excellent for
gene counting158 and multiplexing of samples but cannot detect alternative splicing, single-
nucleotide polymorphisms (SNPs), or other RNA changes that require a whole transcript.
The  best  uses  for  this  method  would  be  experiments  that  require  a  high  number  of
samples (e.g., screens) or where cells are difficult to source and are expensive to cultures
such  as  induced  pluripotent  stem  cells  (iPSCs)  or  small  model  organism  cells.  This
approach could also be used in conjunction with scRNA-seq when higher sensitivity is
required. 
We found 50,000 to be the most optimal number of cells per sample. The handling volume
was  not  too  high,  and  the  clean-up  efficiency  remained  satisfactory.  Increasing  cell
numbers did not yield higher cDNA amounts. RNA extraction using these cell numbers
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yields enough cDNA to be measured on a Bioanalyzer system as an added, optional QC
step. We would strongly suggest using robotic liquid handling systems and automated cell
counting  to  speed up the  RNA extraction,  minimize  the  sample  dropout  and pipetting
errors  for  smaller  amounts  of  cells.  Using  the  robotic  liquid  handlers  would  also
dramatically speed up the whole process and increase throughput. 
4.4.3 The role of IκB kinases in the TLR4 and cGAS-STING signaling pathways
As proof of concept, we prepared 160 low-input samples of 12 different knockout cell lines.
After sequencing and QC, several samples dropped out, and the sequencing depth was
quite uneven between samples. This was most likely caused by unequal numbers of input
cells  in  the  samples,  as  we  lacked  the  capabilities  to  count  cells  in  each  sample
separately. Instead, cell counts were estimated based on the number of cells plated at the
beginning of the experiment. We noted that proliferation differs among clonal knockouts,
most likely leading to the variation in our data. As such, this experiment would benefit from
more accurate cell counting.
The selection of  these KOs could allow us to reconstruct  the cGAS-STING and TLR4
signaling  networks  in  an  unbiased  way.  While  this  dataset  was  rather  limited  by  the
number  of  perturbations  (only  12),  it  was  still  considerably  high  throughput  for  bulk
sequencing (160 samples), and in this regard, it could serve as a blueprint for even larger
studies. Eventually,  this  kind of  setup could be considered for large-scale perturbation
studies.
The  biological  question  was  to  find  transcripts  that  show  a  clear  NF-κB  (RELA)  and
IRF3/7-dependent  signal  and  to  identify  the  relevant  kinases  upstream  of  these
transcription factors. Despite the initial problems, the samples that passed QC clustered
quite well based on the different stimuli used. We observed that samples with essential
genes from their respective pathways deleted, clustered with unstimulated samples. For
example, when the canonical IKKs (CHUCK and IKBKB) or a subunit of NF-κB (RELA),
were knocked out in the TLR4 signaling pathway, the samples clustered with unstimulated
clones. On the other hand, if either one of the TLR4 adaptors (MYD88 or TICAM1) was
perturbed, signaling was still intact, even though to a lower extent. Only when both adapter
molecules were knocked out was the signaling completely terminated. Similarly, the cGAS-
STING  pathway  was  interrupted  when  both  essential  kinases  (IKBKE and  TBK1)  or
transcription factors (IRF3 and IRF7) were knocked out. 
We also found that CHUCK and IKBKB are redundant kinases in the TLR4 associated NF-
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κB pathway and that the kinases TBK1 and IKBKE are redundant in their function for the
cGAS-STING pathway. The finding that  CHUCK  and  IKBKB are redundant was a novel
one since, so far, it has been shown in mouse studies that IKBKB alone is essential for the
activation of the canonical NF-κB pathway159,160. Even more surprising was the finding that
TBK1 and  IKBKE act  redundantly  in  the  cGAS-STING  signaling  pathway  (interferon
response),  especially  when  considering  that  TBK1 is  required  for  interferon  response
induced by TLR4 signaling161.  In this dataset, we can clearly see that Type I interferon
response is not perturbed in either of the  single knockouts (TBK1 and  IKBKE), but it is
abolished in the double knockout samples (Fig. 4.3.7 C). 
However, we could not confirm the requirement of  TBK1  for Type I interferon response
after LPS stimulation (TICAM1 dependent interferon signal). This might be because the
interferon response after LPS stimulation is delayed – the samples were only stimulated
for two hours before harvesting and library preparation. We could still detect an interferon
response after LPS stimulation, albeit a rather weak one (Fig. 4.3.7 C). Despite this, we
identified several well-known ISGs162,163 that were upregulated upon LPS stimulation, such
as  CXCL10,  MX2,  DDX58,  PLA2G4C,  CCL2,  and  CCL8  in  most  of  the  samples.
Additionally, we also found ISGs that showed a clear NF-κB independent induction: IFIT1,
IFIT2, IFIT3, IRF1, and OASL. These transcripts can be particularly useful as they allow
studying interferon induction in an NF-κB independent manner. Knowledge about these
transcripts is especially beneficial when studying pathways that simultaneously impact NF-
κB and interferon signaling, e.g., in the context of genetic screens. Therefore, transcripts
that  can  distinctly  be  assigned  to  either  IRF  or  NF-κB  activation  are  important  for
distinguishing between these pathways using gene expression as a read-out.
SCRB-seq can be used to  conduct  extensive  knockout  experiments  involving  multiple
genotypes and multiple stimuli.  The current  difficulties lie with sample preparation and
RNA  extraction.  Using  low-input  bulk  SCRB-seq  to  detect  major  changes  in  gene
expression is already practical. As shown by Svensson et al. and Heimberg et al., major
changes in gene expression are resistant to noise, and the trade-off between sequencing
depth and cost does not always justify deeper sequencing117,164.  However, to find more
subtle changes in a small number of genes, much deeper sequencing would be required.
We would recommend performing calculations before sequencing to determine the exact
number of samples vs. throughput or perform a small-scale test sequencing.
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5  Human T helper cell differentiation on a single-cell and 
population level
5.1 Introduction
Human CD4+ T helper cell differentiation has been investigated for several decades, and in
many aspects,  it  is  considered to  be  well  understood.  While  basic  principles  such as
distinct cytokine profiles and master transcription factors have been established, recent
advances  in  methods  have  opened  new  avenues  of  inquiry.  Some  of  the  remaining
questions include: how and when are cell fates decided following the activation, how do T
helper  subsets  differ  from  each  other  on  the  single-cell  level,  and  how  does  the
transcriptional profile of differentiating T helper cells change over time115,165.
Under  physiological  conditions,  the  T helper  cell  subsets  arise  based on location and
pathogen  exposure64.  In  vitro,  we  can  recreate  conditions  to  skew  or  polarize  the
development of naive T helper cells by using different cytokines and antibodies, together
with the initial activation and proliferation signal166 (Fig. 5.1). It is also possible to activate
the CD4+ T cells without  any additional  cytokine skewing and let  them proliferate and
acquire  a  phenotype  spontaneously.  These  cells  are  called  TH0,  and  are  sometimes
considered  to  still  retain  their  multipotentiality  (they  can  still  acquire  TH1  or  TH2
characteristics)167 (Fig. 5.1).
Figure 5.1 In-vitro CD4+ T helper cell differentiation. Adding
specific  cytokines  during  the  activation  process  makes  it
possible  to  skew  T  helper  cell  development  towards  the
desired lineage.  Omitting cytokines under  the non-skewing
condition causes T helper cells to commit towards TH1 or TH2
fate spontaneously. 
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T helper cell  lineage is usually assayed by measuring cytokine production and release
either by ELISA or flow cytometry.  High levels of  IFN-γ characterizes TH1 and TH17 T
helper cells, whereas TH2 cells produce less predominantly IL-4. As mentioned previously,
activated  naive  T  helper  cells  spontaneously  acquire  either  TH1  or  TH2  (rarely  TH17)
characteristics. Although T helper cells can be influenced through both an autocrine and
paracrine fashion, it is still possible that a population of non-skewed differentiated T helper
cells contain both TH1 and TH2 like cells. 
5.2 Overview
To find out more about cell fate decisions on the single-cell level, we employed SCRB-seq
to  capture  and  sequence  non-polarized  but  activated  CD4+ T  helper  cells  at  several
different time points.  While preparing for the experiment,  we also tried to optimize our
experimental  design to  mitigate known technical  variations that  can affect  plate-based
methods and give rise to batch effects. In analyzing this first set of single-cell data, we
were unable to detect discrete subsets of differentiated T helper cells on a single-cell level.
We  reasoned  that  one  issue  hindering  us  from  detecting  T  helper  subsets  was  the
inherently low expression levels of many lineage-specific transcripts, such as cytokines
and  transcription  factors.  To  compensate  for  that  we  repeated  this  experiment  with
restimulating the cells before cell capture as well as with increased differentiation time.
Because of these modifications, we noticed a marked increase in captured transcripts.
However, we could still not verify any distinct T helper subsets. 
In order to validate our scRNA-seq findings and to rule out low sensitivity as a factor, we
conducted a third experiment. For that we set up a low-input bulk sequencing pipeline to
generate,  assay,  and sequence T helper  cells.  As positive  controls,  we also  prepared
knockout  naive  T  helper  cells  deficient  for  TBX21 or  GATA3  to  force  the  lineage
commitment  towards  TH2  or  TH1,  respectively.  Thanks  to  bulk  sequencing’s  increased
sensitivity, we were able to separate control samples into distinct T helper types, but only
based on their cytokine expression. However, this distinction vanished when comparing
the whole transcriptome of those samples.
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5.3 Results
5.3.1 Establishing in vitro differentiation of T helper cells
To determine whether T helper differentiation under non-skewing conditions in vitro indeed
leads to spontaneously differentiated T helper cells, we cultured naive CD4+ T cells under
non-skewing  conditions  (see  methods  3.2.3).  As  positive  controls,  we  added  IL-12  to
induce TH1 skewing, IL-4 and IFN-γ neutralizing antibodies to induce TH2 skewing, and IL-
1β to induce TH17 skewing. After 14 days of differentiation, we confirmed the successful
differentiation  of  T  helper  cells  on  a  population  level  by  ELISA.  As  expected,  IFN-γ
production  was  mainly  seen for  TH1 and TH17  skewing conditions,  while  considerable
amounts of IL-4 were only seen for TH2 skewing conditions. Non-skewing conditions led to
comparable  levels  of  IFN-γ and  IL-4  production  as  observed  in  TH2  or  TH1  skewing
conditions, respectively (Fig. 5.3.1. A). 
Figure 5.3.1 (A) 200 000 naive T helper cells were plated per sample, activated, and polarized as in Figure
5.1. After 14 days, the cells were stimulated for 24h with PMA (50 ng/ml) + Ionomycin (1µg/ml), after which
the supernatant was collected, and the release of IFN-γ and IL-4 was measured by ELISA. Graph shows
mean +/- SEM of three donors. (B) 200 000 naive T helper cells were plated per sample, activated, and
polarized towards TH0, TH1, and TH2 lineage. After 14 days, the cells were stimulated for two hours with
PMA (50 ng/ml) + Ionomycin (1 µg/ml),  after  which the intracellular  cytokine staining was performed as
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described in methods 3.2.11. One of three biological replicates per condition is shown.
The disadvantage of bulk measurement techniques such as ELISA is that one cannot draw
any conclusions with  regards to  the  proportion  of  cells  that  commit  to  a  particular  TH
phenotype of  interest.  However,  this  problem can be overcome by assessing cytokine
production on a single-cell level using flow cytometry. Conducting such analyses provided
a far more dichotomous picture. 
We repeated the previous experiment, omitting the TH17 condition this time, as it did not
produce measurable levels of IL-17 (data not shown). TH1 skewing conditions induced a
sizable proportion of IFN-γ single-positive cells,  a fraction of IFN-γ/IL-4 double-positive
cells, and only a small proportion of IL-4 positive cells. On the other hand, TH2 skewing
conditions  led  to  a  single  population  of  IL-4  positive  cells.  Interestingly,  non-skewing
conditions resulted in an equal proportion of IFN-γ single positive and IL-4 single-positive
cells (both around 20%) and an additional population of IFN-γ/IL4 double-positive cells
(around 10%). So in total, approximately half of the T cells population displayed signs of
lineage commitment under non-skewing conditions, with a roughly equal share of cells of a
TH1 and TH2 profile (Fig.5.3.1 B). We, therefore, opted to use this non-skewing setup to
perform a scRNA-seq experiment to further characterize the spontaneous differentiation of
T cells under non-skewing conditions.
5.3.2 SCRB-seq causes strong batch effects that need to be corrected in 
downstream analysis
To  identify  novel  transcripts  responsible  for  T  helper  cell  differentiation,  we  obtained
PBMCs from two different donors and purified naive CD4+ T helper cells in two different
ways. We used magnetic assisted cell sorting or MACS kit from Miltenyi Biotec that yields
CD4+ T cells with roughly 90% purity (as stated by the manufacturer) or FACS sorting for
CD3+, CD4+, CCR7+, CD45RA+ positive T cells. FACS sorting should result in much higher
purity (well over 95%168) of naive CD4+ T cells than MACS sorting. We reasoned that this
increased purity  ensures that  the CD4+ T cell  differentiation  would not  be affected by
potential antigen-presenting cells or influenced by contaminating memory T cells leftover
from PBMCs isolation. 
Both samples were plated and activated, then cultured as described in methods, chapter
3.2.3. Cells were harvested at zero, four, eight hours, and one, three, and seven days after
stimulation, then sorted into a 96-well PCR plate pre-filled with lysis buffer. These plates
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were  then  flash-frozen  on  dry  ice.  At  each  time  point,  two  plates  were  sorted  for
sequencing (a total of 2256 single cells). Library preparation started one day after the final
time-point and followed the SCRB-seq v.3 protocol. As batch effects are a known problem
for plate-based single-cell  sequencing protocols,  we randomized the order of  plates to
minimize the batch effect between plates169,170. Plates were prepared two at a time (Table
5.3.1) until Nextera XT library preparation step. Starting from this point, all samples were
handled simultaneously. Samples were sequenced on Illumina HiSeq 1500 platform, with
each experiment on a separate lane.
zUMIs software was used  for  demultiplexing, mapping, and  feature  counting. A total of
2109  out  of  2256  cells  passed  the  QC.  Standard  Seurat  workflow was  followed  until
dimensionality  reduction  and  clustering.  In  Figure  5.3.2  A,  batches  corresponding  to
capture plates are visible on a UMAP plot. Also, earlier time points seem to be more prone
to technical variation. The later time points (three days and seven days) already grouped
with each other even without any batch effect correction but could still be separated based
on which lane the cells were sequenced. It is, therefore, vital to correct for batch effects
before continuing with the analysis. We used Seurat’s SCTransform155 function to regress
out the unwanted variation.
This specific experimental setup resulted in three distinct sources of technical variation:
The first being MACS purified cells in lane-1 compared to the FACS sorted cells in lane-2
of the Illumina HiSeq flow cell (batch 1). The second was originating from the pairs of
plates prepared together (batch 2). Lastly, each plate corresponds to a time-point and a
donor (batch 3)(Table 5.3.2). 
Table 5.3.2 Experimental design. Overview and order of plates from both experiments. Time shows how
long after  the activation the cells  were harvested.  Randomized order  of  library  preparation indicated by
“Prep.order”. Batch 1 indicates pairs of plates that were handled together during library preparation. Batch 2
indicates each plate. Batch 3 indicates different donors and sequencing lanes.
A clear indication of the batch effect in our data was the distinct clusters that cells formed
in UMAP plots. We can see that batches are dictated mainly by the capture and RT plates
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Time Method Plate # Prep.Order Batch 1 Batch 2 Batch 3 Time Method Plate # Prep.Order Batch 1 Batch 2 Batch 3
0h MACS 1 4h-1 a a a 0h FACS 13 0h-1 g m b
0h MACS 2 7d-2 a b a 0h FACS 14 4h-2 g n b
4h MACS 3 8h-2 b c a 4h FACS 15 8h-2 h o b
4h MACS 4 24h-1 b d a 4h FACS 16 24h-1 h p b
8h MACS 5 0h-1 c e a 8h FACS 17 4h-1 I q b
8h MACS 6 4h-2 c f a 8h FACS 18 7d-2 I r b
24h MACS 7 7d-1 d g a 24h FACS 19 7d-1 j s b
24h MACS 8 3d-1 d h a 24h FACS 20 8h-1 j t b
3 days MACS 9 24h-2 e I a 3 days FACS 21 24h-2 k u b
3 days MACS 10 8h-1 e j a 2 days FACS 22 3d-1 k v b
7 days MACS 11 3d-2 f k a 7 days FACS 23 3d-2 l w b
7 days MACS 12 0h-2 f l a 7 days FACS 24 0h-2 l x b
Experiment 1 MACS purified naive CD4+ T-cells Experiment 2 FACS sorted naive CD4+ T-cells
of origin when we overlay the plot with index sort information (Fig. 5.3.2 A). Each small
grouping of cells is one of the two plates per time point and per donor. Also visible is the
separation by a donor that would not be expected to such a degree. We can correct for
batch effects by trying to regress out the confounding variables listed above. 
When  controlling  for  batch  1  (donors  and  lanes),  we  did  not  notice  any  major
improvements  in  the  cells’  positioning  (Fig.  5.3.2  B).  When  using  batch  2  as  the
confounding variable, we noted quite an improvement in cells’ positioning. However, some
time points (especially the earlier ones) of the same donor remained separated (Fig. 5.3.2
C). Only when we corrected for each capture plate (batch 3) did we finally lose the distinct
clustering seen in previous plots (Fig. 5.3.2 D). This somewhat surprising finding implies
that our SCRB-seq protocol causes the most technical variation in the earliest steps of the
library preparation; cell capture and lysis.
For  further  analysis,  batch  corrected  data  where  individual  plates  are  considered
confounding variables were used unless stated otherwise. 
Figure 5.3.2 UMAP plots of scRNA-seq data. SCRB-seq has a strong batch effect caused by differences in cell
capture, lysis, RT, and library preparation. (A) uncorrected data, (B) sequencing lane/donor corrected data, (C)
handling batch corrected data (D) individual plates corrected data. Upper panels are colored by time after
activation, and lower panels are colored by the donor. All UMAPs are based on the top 3000 HVGs.
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5.3.3 CD4+ T helper cells differentiated in-vitro and under non-skewing condition 
yield a heterogeneous and continuous population
Our  data  revealed  that  CD4+ T  helper  cells  form  one  heterogeneous  and  continuous
population with no distinct sub-populations. When overlaying the UMAP plot with capture
time information, we can see that the primary source of variation is the differentiation time
(Fig. 5.3.2 D, upper panel). Differentiated cells do not group into smaller, distinct clusters.
If anything, the cells from  earlier time points exhibit more variation between themselves
and between donors and tend to form small sub-populations because of that. One possible
explanation could be that naive CD4+ T cells are physically much smaller than activated
and  differentiating  cells.  Larger  cells  usually  contain  more  mRNA154.  We  could  find
indications  of  that  in  the  uncorrected  data,  where  earlier  time  points  formed  distinct
clusters based on their plate of origin, the later time points mixed better. Also, cells from
later time points had more reads associated with them (data not shown). 
UMAP projection of differentiated cells does not reveal groupings that could be attributed
to any of the CD4+ T helper cell subsets. Unbiased clustering (Louvain algorithm based on
SNN as implemented by Seurat’s workflow) failed to identify any meaningful subsets in our
data.  Depending on the parameters used, we see either two main clusters,  one early
group (mainly comprising of cells from zero, four, eight hour, and one day post-activation)
and a late group of cells (mostly one, three, and seven days post activation) or many,
smaller but biologically meaningless clusters (data not shown).
When looking at the expression of lineage-specific cytokines, we found that many of the
same cells that express high levels of the TH1 defining cytokine IFN-γ also co-express TH2
specific cytokines such as IL-4 and IL-13. We did notice several cells that only expressed
IL-4 or IL-13 and no IFN-γ, but they were randomly distributed and formed no clusters with
other similar expression pattern cells. This could be due to the very low expression levels
of those cytokines, where only a single read, or two, would qualify those cells as highly
expressing either IL-4, or IL-13, or both. Expression of lineage-specific transcription factors
reflected  the  same  image  as  did  cytokine  expression.  There  was  a  time-dependent
expression gradient in GATA3, and TBX21 levels; other than that, no region or a cluster of
exclusive expression were detected (Fig. 5.3.3 A).
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Figure 5.3.3 (A) Gene expression plots in UMAP projection. The positioning of cells is identical to Figure
5.3.2.D UMAPS are based on top 3000 HVGs. (B)  Heatmap based on top 50 HVGs. Based on these genes’
expression, cells from the earlier time points cluster together, as do cells from later time points. Cytotoxic
marker genes are highlighted. (C) Violin plots of highly expressed cytokines, chemokines, and activation
markers.
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Highly  variable  genes (HVGs)  (Fig.  5.3.3  B)  contained  many cytotoxicity  markers  like
granzyme A, B, and H (GZMA, GZMB, GZMH) as well as granulysin (GNLY). These genes
are  typically  associated  with  CD8+ or  cytotoxic  T  cells171.  Still,  in  our  experimental
conditions, almost all of the differentiated CD4+ T cells from day three onward express high
levels of GZMB, and many of them also co-express GNLY and GZMH as well as GZMA.
If we consider these HVGs as markers for differentiation, we observe that the cells began
differentiating around the third day. The expression of those markers was still increasing
on day seven. Additionally,  CD69,  a classical T cell  activation marker,  started showing
down-regulation around day one, but it did not quite reach the expression levels it had in
naive T cells by day seven (Fig. 5.3.3 C). Taken together, this suggests that T helper cells
activated and expanded under non-skewing conditions need around three days to start
showing differentiation effects but probably need longer than seven days for final lineage
commitment. 
5.3.4 T helper cells differ in their early and late response to activation
As we saw in the previous chapter, there seems to be a break in our data where T helper
cells go from reacting to an activation signal to increasing the expression of cytotoxicity
markers  and  certain  lineage-specific  cytokines.  In  short,  it  looks  like  there  are  two
different processes going on. To determine what transcriptional changes occur at those
points,  we  decided  to  use  our  SCRB-seq  protocol’s  full  capabilities.  Since  we  had
information of when and from which plate the cells originated, we could directly compare
selected time points. 
Looking at genes differentially expressed (DE) between four hours after activation vs.
baseline (zero hours), we detected many immune response and, more specifically, T cell
activation  markers  like  CD69,  TNF,  LTA,  TRAC,  CD3D,  NFKBID  (Fig.  5.3.4  A).  To
validate our findings, we conducted pathway enrichment analysis using the PANTHER
Pathway  tool.  Doing  so,  we  found  that  many  gene  ontology  (GO)  terms  related  to
immune  response,  gene  expression,  and  response  to  stimulus  were  significantly
enriched (Fig. 5.3.4 B). 
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Figure 5.3.4 (A)  A volcano plot  showing DE results between cells from four hours vs.  zero hours post-
activation. (B) Pathway enrichment analysis based on all upregulated genes with FDR < 1% from (A). (C) A
volcano plot showing DE results between cells from seven days vs. zero hours post-activation. (D) Pathway
enrichment analysis based on up-regulated (LFC > 1) genes with FDR < 1% from (C).
We also conducted the same analysis between seven days and baseline (zero hours).
This time, we discovered that many upregulated transcripts were part of the top HVGs,
thus confirming that most of the variation in our data comes from later time points. The
differentiating T helper cells show strong up-regulation of many cytokines and granzymes
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such as TNF, GZMB, CSF2, IFN-γ, as well as well-known differentiation markers such as
the IL-2 receptor (CD25) and S1004A. Also, the GO analysis revealed different enriched
pathways  compared  to  earlier  results.  GO  terms  like  cytokine  stimulus  and  chemical
signaling dominate the top of the list. Unlike the activated T cells, differentiated T cells
show  a  substantial  down-regulation  in  the  expression  of  many  transcripts,  including
transcription  factors  such  as  ONECUT3  and  HIF3A.  We  also  performed  the  pathway
enrichment  analysis  on  this  set,  but  no  pathways  with  an  FDR of  10% or  less  were
retrieved  as  a  hit.  This  is  not  an  unexpected  result  insofar  as  many  down-regulated
transcripts in that list are pseudogenes (AC092329.3, AL360227.1, AL139220.2).
5.3.5 Restimulating CD4+ T helper cells
When trying to assay CD4+ effector T cells with conventional methods like ELISA and flow
cytometry, it is necessary to stimulate the cells to increase cytokine production to a level
where it becomes detectable (Fig. 5.3.5 A). This stimulation, also called restimulation, can
be achieved by adding anti-CD28/anti-CD3 ABs or by using chemical  compounds that
mimic TCR engagement. One well-established stimulation procedure is the use of PMA
and Ionomycin. PMA (phorbol-12-myristate-13-acetate) can activate protein kinase C (an
essential part of TCR signaling172), and Ionomycin functions as a calcium (Ca2+) ionophore
that leads to an increased intracellular Ca2+  concentration. Together they mimic the TCR
activation  signal  and  lead  to  increased  cytokine  expression173.  Although  short-term
restimulation with PMA/Ionomycin does not seem to affect T cell viability174, over time, cells
will  succumb  to  activation-induced  cell  death  (AICD)175,  thus  impacting  their  gene
expression profile. Since RNA-seq is much more sensitive than any other conventional
assays,  we initially  omitted  restimulation  before  cell  capture  from our  first  scRNA-seq
experiment. However, since we could not detect different T helper types, we reasoned that
maybe PMA/Ionomycin stimulation might help us capture more lowly expressed genes,
which might help us in assigning cell types. FACS purified naive T cells from two donors
were plated and activated. During the harvesting of cells at four different time points,  we
restimulated half of them with PMA and Ionomycin (see methods 3.2.3) (Table 5.3.5).
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Table 5.3.5 Experimental setup. Overview and order of plates from both experiments. Time shows how
long after the activation, the cells were harvested. Method – naive CD4+ T cell isolation method. “Prep.order”
- randomized order of library preparation to reduce the batch effect. Batch 1 indicates each plate. Batch 2
indicates pairs of plates that were handled together during library preparation.
We subjected 94 cells from each donor from each time point and stimulation condition to
single-cell sequencing (total of 1504 cells). 1397 single-cells passed the QC and filtering.
We also noticed some batch effect in this dataset, but it was less pronounced, primarily
because the  cells  from  later  time  points  are  less  affected  by  technical  noise;
differentiated cells are  physically bigger and transcriptionally more active (Fig 5.3.5 C).
After correcting for the capture plate again, the two main populations of cells remained:
activated but resting T cells and restimulated T cells (Fig. 5.3.5 B). Restimulated cells
and cells from later time points have more reads associated with them, translating into
more UMIs and transcripts (Fig. 5.3.5 C).
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Time Method Donor Plate # Stimulus Prep.Order Batch 1 Batch 2
0h FACS Donor 3 1 na D3_14d_7 a a
0h FACS Donor 3 2 na D4_0h_1 b a
0h FACS Donor 4 3 PMA/iono 2h D4_7d_6 c b
0h FACS Donor 4 4 PMA/iono 2h D3_7d_5 d b
3 days FACS Donor 3 5 na D4_14d_8 e c
3 days FACS Donor 3 6 na D3_0h_1 f c
3 days FACS Donor 4 7 PMA/iono 2h D3_7d_6 g d
3 days FACS Donor 4 8 PMA/iono 2h D4_3d_4 h d
7 days FACS Donor 3 9 na D4_7d_5 I e
7 days FACS Donor 3 10 na D3_14d_8 j e
7 days FACS Donor 4 11 PMA/iono 2h D4_0h_2 k f
7 days FACS Donor 4 12 PMA/iono 2h D3_3d_3 l f
14 days FACS Donor 3 13 na D3_3d_4 m g
14 days FACS Donor 3 14 na D4_3d_3 n g
14 days FACS Donor 4 15 PMA/iono 2h D3_0h_2 o h
14 days FACS Donor 4 16 PMA/iono 2h D4_14d_7 p h
Figure 5.3.5 (A) FACS-based detection of hallmark T helper cell cytokines requires restimulation.
200 000 naive T helper cells were plated per sample and activated. After 14 days, the cells were either left
unstained, unstimulated,  but  stained,  or restimulated and stained. One of  three biological  replicates per
condition is shown. (B) UMAP plot of 1397 single cells from two different donors and four time points. Cells
are color-coded based on the PMA/Ionomycin restimulation. (C) Barplots showing the mean of UMIs and
genes per cell detected at each given time point in restimulated vs. resting cells. Each time point had the
same number of input cells, and libraries were pooled in an equimolar fashion for sequencing.
5.3.6 Restimulation increases CD4+ T helper cell transcriptional activity and 
enhances the expression survival and activation markers
To control for PMA/Ionomycin restimulation effects, we conducted DE analysis comparing
all the restimulated cells to all resting cells from each time point. As expected, we saw up-
regulation in T cell activation marker genes like CD69 and IL-2 and pro-survival markers
such as MYC, PIM3, and TNF (Fig. 5.3.6 A). Pathway enrichment analysis based on all the
upregulated (log fold change – LFC>1 and FDR<1%) genes also revealed cell  death-
related terms like regulation of apoptotic process and regulation of cell death (Fig. 5.3.6
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B). 
Figure 5.3.6  (A)  Volcano plot  showing  DE results  between  restimulated and resting  cells.  (B)  Pathway
enrichment analysis based on up-regulated genes (LFC > 1, FDR < 1%) from (A). 
5.3.7 Cytokine response is increased in restimulated CD4+ T helper cells
As mentioned above, PMA/Ionomycin stimulation increased transcription and caused up-
regulation of pro-survival markers and activation markers. In general, many genes were
more highly expressed in the restimulated group. Against our initial expectation, increased
transcription still did not reveal any distinct T helper cell subsets, as we had previously
observed them in  our  FACS-based analysis.  We still  detected a clear  time-dependent
expression  of  cytokines like  IL-4 and  INF-γ and  cytotoxicity  markers  (GZMB,  GZMA),
indicating T helper cell differentiation.  Similar to  the previous dataset, we again  noticed
that  the same cells  (or  group of  cells)  that  express  high levels  of  INF-γ (TH1 specific
cytokine) also expressed high levels of IL-13 (TH2 specific cytokine) (Fig. 5.3.7. A).
We could not detect any  additional  meaningful  clusters in our data other than the two
already mentioned, the clustering based on PMA/Ionomycin stimulation and the gradient of
differentiation time.  Louvain clustering  based on the  SNN algorithm showed two main
clusters in restimulated cells and three in resting cells, roughly corresponding to an early-
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to-mid  and a late  cluster  (Fig.5.3.7.B).  Hierarchical  clustering  based on top  50 HVGs
revealed that  cells  grouped mostly  based  on time  after  activation and  less  based on
restimulation (Fig.5.3.7 C). 
Using our  scRNA-seq data,  we confirmed that  PMA/Ionomycin  restimulation increased
cytokine expression. Cells show restimulation effects, mostly indicated by the expression
of cell survival and activation markers such as  MYC,  PIM3, IL-2, and increased overall
transcriptional activity. The expression of T helper cell hallmark cytokines is also increased
compared to resting cells. However, like the resting cell population, the restimulated cells
also fail to segregate into distinct T helper cells’ subsets (Fig. 5.3.7 B).
Figure 5.3.7. (A) Gene expression plots in UMAP projection. The positioning of cells is identical to (B). (B)
UMAP plots of restimulated and unstimulated T cells. Cells are color-coded based on the differentiation time
(left) and Louvain clustering (right). All UMAPs are based on the top 3000 HVGs. (C) Heatmap based on the
top 50 HVGs. Cells and genes are hierarchically clustered based on euclidean distance.
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5.3.8 Trajectory inference by Slingshot roughly follows the time gradient 
Lastly,  we  wanted  to  leverage  the  power  of  trajectory  inference  (TI)  to  detect  time-
dependent regulators of human T helper cell differentiation fates  in  our single-cell data.
Because the SCRB-seq data exhibits an inherently strong batch effect, we could not use
some algorithms like Monocle or Destiny. We, therefore, decided to use Slingshot, a tree-
based TI algorithm176. We split the data into two sets: restimulated and resting, because
both populations exhibited similar expression profiles, and we were not interested in the
differences between stimulation  conditions.  We analyzed  them  separately,  and TI  was
based on UMAP reduced data. Slingshot identified only one trajectory in either dataset,
and it roughly corresponds to the time gradient (Fig. 5.3.8 A). Since the signal was much
stronger  in  restimulated  population,  we  continued  our  analysis  with  only  that  dataset.
Genes that  changed their  expression most  significantly  over  the identified pseudotime
trajectory were mostly cytotoxicity markers such as GZMB, GZMH,  and cytokines IFN-γ,
CSF2, CCL4L2, IL-13, CCL5 (Table.5.3.8). The same genes were also identified by DE
analysis of restimulated cells 14 days post activation vs. 0 hours (Fig.5.3.8 B and Table
5.3.8). 
Figure 5.3.8 (A) UMAP projection of restimulated T cells overlaid with Slingshot’s inferred trajectory in pink.
Cells are colored by differentiation time. (B) Volcano plot showing DE results of restimulated cells between
14 days and 0 hours. 
Next, we looked for transcription factors among pseudo-temporally expressed genes and
found seven with FDR less than 1% (Table 5.3.8). All of them are well known in the context
of T helper cell differentiation or cellular activation and proliferation. ZBED2 is a zinc finger
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protein recently described as  IRF1 antagonist177.  JUND is part of the  AP1 transcription
factor complex and protects cells from apoptosis and senescence178.  GATA3 is a well-
known transcription factor and a master regulator of TH2 lineage. RUNX3 is implicated in
cytotoxic T cell development and a tumor supressor179,180.  BHLHE40 has been shown to
regulate  CSF2 production  in  mice  and  to  be  essential  for  pathogenicity  in
neuroinflammation181. FOXP1, similar to FOXP3, is a known regulator of regulatory T cell
(Treg)  development182.  HDGF has  been  tied  to  cellular  growth,  proliferation,  and
differentiation183.  NR4A3 (together with NR4A1) is known to be differentially expressed in
activated T cells184 and implicated in CD8+ T cell development185. 
Table 5.3.8 Slingshot TI  and DE results. On the left,  the top 10 most significantly  upregulated genes
between zero hours and 14 days. In the middle, the top 10 genes identified by Slingshot as having the
highest significant associations between expression and pseudotime. On the right, all transcription factors
differentially expressed along the Slingshot lineage with FDR<1%
5.4 Analysis of T helper cell transcriptome on a population level
5.4.1 Low-input bulk sequencing for increased sensitivity
Although SCRB-seq is one of the most sensitive single-cell RNA-seq methods available137,
it may still lack sensitivity to detect T helper cell lineages’ subtle differences. To address
that potential issue, we prepared libraries of 56 bulk samples in restimulated and resting
conditions. We also included in those samples knockout T cells deficient for either master
transcription  factor  GATA3 or  TBX21 (GATA3-/- and  TBX21-/- respectively).  In  order  to
achieve homogeneous populations of  cells  that  were reliably  deficient  for  the targeted
gene  of  interest,  we  prepared  samples  from  monoclonal  colonies  by  limiting  dilution
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Top 10 DE genes 0 h vs. 14 days Top 10 genes identified by Slingshot Top TFs identified by Slingshot
# Genes LFC FDR # Genes FDR # Genes p.val FDR
1 CSF2 4.9 3.15E-297 1 CSF2 3.29E-44 1 ZBED2 2.44E-29 7.32E-26
2 GZMB 4.4 7.36E-272 2 GZMB 2.19E-43 2 JUND 1.76E-19 5.29E-16
3 IFNG 4.5 2.70E-258 3 GZMH 2.22E-42 3 GATA3 1.83E-13 5.49E-10
4 CCL4 4.2 2.60E-201 4 LGALS1 1.19E-37 4 RUNX3 1.16E-09 3.47E-06
5 IL13 3.7 4.36E-175 5 IFNG 7.36E-33 5 BHLHE40 2.74E-09 8.23E-06
6 XCL1 3.7 1.31E-126 6 XCL1 2.08E-32 6 FOXP1 1E-06 0.003
7 CCL5 2.6 5.59E-122 7 CCL4L2 1.18E-31 7 HDGF 1.12E-06 0.00335
8 S100A4 2.3 4.89E-116 8 IL13 2.52E-31 8 NR4A3 2.04E-06 0.00612
9 IFITM2 2.4 6.45E-116 9 CCL5 1.47E-30
10 XCL2 3.9 2.09E-90 10 CCL4 1.9E-29
cloning using activated CD4+ T cells that were expanded under non-polarizing conditions
(see  methods  3.2.6  and  3.2.3).  Genotype  and  clonality  were  assessed  using  deep
sequencing (see methods 3.2.7).  After  three weeks,  the samples were split  for  library
preparation  and  analysis  of  cytokine  concentration  in  the  supernatant  by  ELISA.
Unfortunately, we had issues with the RNA clean-up procedure, which led to a loss of half
of all the samples (Table 5.4.1). 
Table 5.4.1 Low-input bulk RNA-seq T helper cells sample table. The numbers indicate how many samples
of each genotype were prepared and how many passed QC.
For positive controls, we chose the transcription factors TBX21 and GATA3 since they are
well-characterized regulators of T helper cell  fates.  TBX21 is required for TH1 cell fate,
whereas  GATA3 inhibits  IFN-γ expression and is considered to be the main regulator of
TH2 cell fate186,187. By knocking out a necessary component in the differentiation program of
a specific T cell lineage, we hoped to skew those samples towards the opposing cell fate.
All  the  samples  were  expanded  under  non-skewing  conditions,  and  all  samples  were
monoclonal, ensuring that each colony would spontaneously acquire only one distinct T
helper cell phenotype. We prepared 32 WT samples to would spontaneously give rise to
different T helper subsets to ensure enough  variability in our dataset  that both T helper
lineage would be represented. 
5.4.2 T helper cell transcriptome on a population level
At  first  glance,  the  results  of  low-input  bulk  data  look  similar  to  single-cell  data.  The
relatively  strong effect  of  PMA/Ionomycin  restimulation  dictated  the  clustering  into  two
main  groups,  regardless  of  the  effects  that  the  genotypes  might  have.  GATA3-/- and




# Genotype PMA/ionomycin Resting Total
1 6/3 6/3 6
2 6/2 6/3 5
3 WT 32/15 32/15 30
TBX21-/-
GATA3-/-
Figure 5.4.2 (A) PCA of low-input bulk RNA-seq data, based on top 1000 HVGs. Colors indicate genotype,
shape PMA/Ionomycin stimulation. (B) Heatmap based on top 100 HVGs. Hierarchical clustering based on
euclidian distance was used for  both  samples and genes.  (C)  Volcano  plot  showing the results  of  DE
analysis between restimulated and unstimulated samples. 
As with single-cell  data, restimulation with PMA/Ionomycin increases the expression of
cytokines and chemokines,  but the effect  on total  reads per  sample was now absent,
possibly  due  to  the  nature  of  the  bulk  sequencing.  We  noticed  the  relatively  high
expression of some cytokines like  CSF2, CCL4, and  IL-13 present in the unstimulated
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samples (Fig.5.4.2 B), which was still significantly increased in the restimulated samples
(Fig.5.4.2 C). Conversely, many of the T helper hallmark cytokines were only expressed at
background  levels  in  unstimulated  samples  (IFN-γ,  IL-5).  Interestingly  none  of  the
granzymes or other cytotoxicity markers (GNLY) showed up as HVGs, as they did in both
of the previous single-cell RNA-seq datasets (Fig.5.4.2 B). These genes are still expressed
at high levels (data not shown) but more uniformly in all samples. Unlike our two previous
single-cell experiments, this time, we did not have samples from different time points along
the differentiation process. This could explain why the cytotoxicity markers were absent in
HVGs as  they  showed a  strong  time-dependent  expression  profile.  This  confirms  our
suspicion that granzymes, especially GZMB and GNLY, are expressed in all differentiated
T helper cells. 
Next, we looked at what effects PMA/Ionomycin stimulation had on the T helper cells on a
population level. Similar to the single-cell data, the T cell activation (CD69,  IL-2) and cell
survival markers (MYC, TNF, NFKBID) were upregulated (Fig.5.4.2 C). Yet, the effect was
much  more  pronounced  than  in  single-cell  data,  resulting  in  many  more  genes  DE
between  restimulated  and  unstimulated  samples.  Additionally,  many  of  the  T  helper
lineage-specific  cytokines  like  IFN-γ,  IL-4,  IL-13,  TNF were  present  in  the  dataset
(Fig.5.4.2 C).  As in the single-cell  data, when we looked for enriched pathways in the
upregulated  transcripts,  we  observed  cell-death-related  pathways  as  well  as  cytokine
signaling (data not shown).
When trying to discern T helper subtypes in the data, we utilized Louvain and hierarchical
clustering methods. Neither method managed to isolate our two control genotypes, TH1
(GATA3-/-) and TH2 (TBX21-/-), into separate clusters. The clustering was mainly defined by
restimulation with additional clusters within the WT samples (Fig.5.4.2 B).
When measuring  the  cytokine  concentrations  in  the  supernatant,  we detected  a  clear
difference  between  the  two  controls  (Fig.5.4.2  E).  However,  when  looking  at  those
samples at a whole transcriptome level, the difference was entirely lost. Only when limiting
our  RNA-seq  analysis  to  T  helper  hallmark  cytokines,  GATA3-/- and  TBX21-/- samples
separated into distinct groups (Fig.5.4.2 F).
83
Figure 5.4.2 (D) Barplots of 4 different T helper lineage defining cytokines. Expression levels measured by
RNA-seq are represented as mean +/- SEM of three independent experiments due to sample dropout, only
two samples of GATA3-/- were used.  (E) Barplots of 4 different T helper lineage defining cytokines. Cytokine
concentration  as  measured  by  ELISA  is  depicted  as  mean  +/-  SEM  of  at  least  three  independent
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experiments. (F) and (G) PCA built using four hallmark cytokines (IFN-γ, TNF, IL-4, IL-13) based on their
expression levels in RNA-seq data (F) and the measured concentrations in the supernatant (G). (H) Volcano
plot showing DE analysis results between restimulated GATA3-/-(n=2) and TBX21-/-(n=3) samples. (I) Volcano
plot showing DE analysis results between unstimulated GATA3-/-(n=3) and TBX21-/-(n=3) samples.
The cytokine expression as determined by ELISA is reflected on mRNA level (Fig.5.4.2 D).
GATA3 KOs express only baseline levels of TH2 specific cytokines (IL-4, IL-13) but have
the  highest  levels  of IFN-γ,  both  on  protein  and  mRNA level.  Whereas  TH1  specific
cytokine expression was reduced in  TBX21-/-. Again, even more so on the protein level.
TBX21 KOs  produced  higher  TH2  specific  cytokines,  but  the  difference  was  less
pronounced for GATA3-/-. However, when looking at the expression levels (both mRNA and
protein)  of  these critical  cytokines in  the WT samples,  we saw that  they were mostly
scattered somewhere in the middle compared to KOs (Fig.5.4.2 F and G). If it were not for
the  extremely  high  IFN-γ expression  in  GATA3-/-,  all  the  samples  would  fall  into  a
continuous population with TBX21-/- on one side and GATA3-/- on the other. The extremely
high IFN-γ expression in GATA3-/- is most likely due to the absence of GATA3 protein since
it has been shown that GATA3 functions as a negative regulator of IFN-γ expression188.
As the last part of the analysis, we looked at the differentially expressed genes between
the  two  genotypes  GATA3-/- and  TBX21-/-.  We  only  found DE in  a  few  transcripts.  In
GATA3-/-  samples, most of the upregulated genes are known to be IFN-γ dependent such
as  CCL4,  CSXL8,  TNF,  HLA-DRA,  HLA-DRB1,  CCL3L1,  CCL4L2 (Fig.5.4.2  H)189,190.
TBX21-/-  express increased TH2 specific  cytokines  IL-5 and  IL-13,  but  interestingly,  the
original TH2 hallmark cytokine IL-4  is not significantly upregulated. This might be entirely
due to the mRNA’s low expression level. Indeed, in the first single-cell  experiment, we
captured almost no IL-4 mRNA. In general, IL-13 seems to be the most easily detected of
all the TH2 hallmark cytokines on protein and mRNA level. 
These  small  differences  between  GATA3-/- and  TBX21-/- are almost  absent when  we
compare the unstimulated samples. The sole upregulated gene in GATA3-/- is CCL5, which
again is known to be upregulated in an  IFN-γ dependent  manner191 (Fig.5.4.2 I).  That




Many recent single-cell sequencing studies of T cells, especially CD4+ T cells, have failed
to show discrete, lineage-committed T helper cell sub-populations112,115,192–196. To determine
discrete T helper subset signatures, we set out to take a more controlled approach using a
more sensitive sequencing method48,137 and in vitro T cell  differentiation.  After purifying
human CD4+ T cells and activating them with bead-bound anti-CD3 and soluble anti-CD28
antibodies, we let them expand for up to seven days in the absence of polarizing cytokines
(non-skewing condition). From prior experience, we knew that naive T cells grown under
such non-skewing conditions gave rise to both TH1 and TH2 like cells when analyzing them
with flow cytometry. With that in mind, we acquired naive CD4+ T cells from two different
donors and set up a time-course experiment to find time-dependent regulators of T helper
cell fates and distinguishable  TH1 and TH2 subsets. Although our single-cell sequencing
method is  considerably  more sensitive than  some commercial  solutions used in  many
published studies151, it has drawbacks. After the initial analysis and data visualization, we
noticed a strong batch effect. It has been noted before that plate-based methods have
more issues with batch effect170, but an additional complicating factor in our case seems to
have been the use of T cells, especially in the resting state. When not activated (naive or
memory), T cells are quiescent, and even though memory T cells are slightly larger, they
are still one of the smallest cells in the human body197. As transcript abundance correlates
with cell size and activity (Fig 5.3.4 C), we noticed a lot more batch effect in earlier time
points compared to later ones. Having less available mRNA to capture seems to make
library preparation more prone to technical variation. The plates themselves were the most
significant source of variation as correcting for the donor, sequencing lane, or handling of
pairs of plates had little impact on results (Fig 5.3.1). This implies that most of the technical
variation is caused by the cell capture and lysis and not by handling during RT and pre-
amplification. 
After  regressing  out  unwanted  variation,  we  were  left  with  a  heterogeneous  and
continuous population of T cells. On one side of the population were the cells from earlier
time points, while the last two time points (day three and seven) positioned to the opposite
side. We could not define any specific regions in that population that could be ascribed to
any of the known T helper types. As expected, there was an absence of T helper lineage
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defining cytokines at earlier time points, but the expression level of these transcripts did
not increase much, even at later time points. IFN-γ was the only hallmark cytokine in the
top 100 HVGs (Fig.  5.3.2 B).  This  discrepancy between protein  level  read-out  (FACS,
ELISA)  and  RNA-seq  data  is  likely  explained  by  the  restimulation  procedures  before
starting the protein level assays.
Even though the lineage-specific cytokines were lowly expressed, we are not limited to
predefined  genes  of  interest  in  scRNA-seq  data.  Instead,  we  can  look  at  the  entire
captured transcriptome of early and late differentiating CD4+ T cells. One interesting gene
that showed up in our first experiment and in all the following ones was CSF2. CSF2 or
Granulocyte-Macrophage Colony-Stimulating Factor  GM-CSF  is  usually  described as a
hematopoietic-cell  growth factor198,  but  it  has also been associated with  T helper  cells
since Mosmann et al. first described different T helper types. In their study, they assigned
the expression of CSF2 to TH1 cells165. More recently, however, there have been multiple
groups  trying  to  associate  the  production  of  CSF2 with  a  novel  T  helper  cell  type
107,108,195,199. We noticed a relatively high expression of CSF2 in late differentiating T helper
cells.  Considering all  three experiments together,  we see a relatively uniform and high
CSF2  expression  dependent  on  differentiation  time  and  restimulation.  Additionally,  we
found  no  DE  of  CSF2  between  GATA3-/- and  TBX21-/- even  though  CSF2 is  often
associated with TH1 fate (Fig.5.3.2. C, Fig.5.3.6 A, Fig.5.4.2 C and B).
Another unexpected result was a high granzyme expression (GZMB, GZMA, GZMH) in
mid to late differentiating T helper cells. Granzymes are usually associated with cytotoxic T
cells. CD8+ T cells use granzymes to trigger apoptosis in target cells200. However, there
have been reports of cytotoxic CD4+ T cells over the past two decades201,202. More recently,
the discoveries facilitated by scRNA-seq have revealed that granzymes, especially GZMB,
are present in activated and memory CD4+ T cells112,113,193,195,203. It seems that granzyme
production is a part of the normal functioning of T helper cells, and cytotoxicity might not
only be a function of CD8+ T cells. CD8+ T cells kill  cells by releasing perforins which
polymerase into pores in the lipid bilayer of target cells. Although the pores in the target
cell  are  already  fatal,  the  killing  efficiency  is  increased  further  by  the  release  of
granzymes64. It is conceivable that in this, the CD8+ and CD4+ T cells can cooperate in
killing target cells, where CD8+ T cells provide perforin and some granzymes, and CD4+ T
cells release additional granzymes. Moreover, there could be as of yet unknown role for
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granzymes in helper T cells. 
As we already mentioned, there is a marked difference in the cells between early and late
time points. To explore this further, we looked for DE genes in each of these time points. In
the  four-hour  post-activation  cells,  we  notice  upregulation  in  many  classical  activation
markers and very few cytokines. Whereas in the late time point cells (three and seven
days), there is a significant increase in cytokines, chemokines, and granzymes. Our first
experiment  indicates that  it  takes about  three days from the initial  TCR stimulation to
detect  differentiation-related  transcriptional  changes  that  indicate  a  memory  T  cell
program. Somewhat faster than 7-15 days as described in the literature204. However, the
difference might be in the lag between transcriptional changes and protein expression 205.
We  also  notice  a  continued  increase  in  the  numbers  of  cells  that  produce  T helper-
associated  cytokines  along  the  differentiation  time.  Not  all  cells  are  CSF2 or  GZMB
positive by day 7 (Fig.3.2 C), which indicates that further increasing the differentiation time
might yield more informative results. 
Because of the generally low expression levels of T helper cell-associated cytokines, we
decided to  repeat  the experiment  with  restimulated T cells,  and we also increased the
differentiation time. Since we did not notice any significant changes between the two ways of
purifying naive CD4+ T cells, we decided only to use FACS purified T cells in our next
experiment.  We  tried  to  reduce  the  known  batch  effect  even  further  by  sorting  both
restimulated and resting cells onto the same plate and pooling the libraries to run on the
same lanes. Despite these precautions, we still noticed some batch effect between capture
plates, but it was less pronounced, mostly because more cells in this dataset were from later
time points when they are less affected by technical noise as they are physically bigger and
transcriptionally more active. Still, we needed to consider this in the analysis.
PMA  and  Ionomycin  stimulation  had  the  expected  effect  of  increasing  the  cytokine
expression174, and the T cells fell into two clusters based on the stimulation (Fig. 5.3.5. B).
Earlier time points were less affected by restimulation as it is effectively just a more potent
TCR stimulus. Due to the restimulation, we detected more T helper cytokines from both TH1
and TH2 lineage, but no clear sub-populations of T helper cells were visible. The PMA and
Ionomycin stimulation does not seem to affect the T cells negatively174. In our hands, the
two-hour restimulation not only helped to induce more cytokines, but restimulated cells also
showed increased transcription. For each day, the average number of reads, UMIs, and
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genes was higher in the restimulated group (Fig.5.3.4 C). As with the previous experiment,
we found time-dependent changes in gene expression. Both restimulated and resting cells
behaved  similarly,  but  the  cytokine  and  granzyme expression  was  much  higher  in  the
restimulated cells. We detected an increased expression of granzymes and CSF2 in both
populations, especially in later time points of restimulated cells (Fig.5.3.6 A). 
Although no distinct sub-populations were immediately detectable, we still used Seurat’s
built-in Louvain clustering algorithm based on SNN to find possible memory T helper cell
regions in our data. Since there is no well-defined approach to selecting the parameters
for neighbor calling and clustering, one should interpret these results carefully115. We found
that four to five clusters describe our data the best; two clusters of early differentiating cells
and two clusters in late ones, separated by restimulation (Fig.5.3.6 B). Allowing for more
clusters to be assigned, the algorithm started finding smaller groups in the early instead of
the late differentiating cells, especially in the resting population. This was most likely due
to higher variability caused by technical noise, the same reason we saw a more pronounce
batch effect in the earlier population of cells. No smaller clusters were detected in the late
time points regardless of the restimulation. Even though clustering did not identify T helper
subsets, we still used trajectory inference analysis. Because of the strong batch effect in
our data, we could not use some TI methods such as Monocle206 and Destiny207 as they
rely on their own dimensionality reduction methods, and the batch effect skews the results
(data not shown). We followed Saelens et al. recommendations and chose one of the top-
performing  TI  tools called Slingshot176.  In  comparison with other  methods,  Slingshot  is
especially good at ordering the cells and for branching lineage assignment60.  We also
chose only the restimulated population of T cells for this analysis for two reasons. First, the
restimulation increased the cytokine expression and so increased the biological  signal
strength,  and second,  having both resting and restimulated cells  in the same analysis
confused  the  algorithm  and  only  produced  bifurcating  lineages  between  the  two
stimulation  conditions.  The  latter  case  was  not  useful  as  it  resulted  in  transcripts
differentially expressed between stimulation conditions which we already knew. However,
as with clustering, even when running the TI algorithm on restimulated samples only, we
found  no  diverging  paths  nor  managed  to  identify  different  memory  T  helper  cells.
Slingshot inferred a single trajectory that followed the main variation in the dataset – the
differentiation  time.  The  same  transcripts  were  identified  by  Slingshot  and  differential
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expression  analysis  between  zero  hours  and  14  days  (Fig  5.3.8  A and  Table  5.3.8).
Because  Slingshot  utilizes  reduced  data  and  dimensionality  reduction  can  introduce
distortions  into  RNA-seq  data116,  we  also  tested  Slingshot’s  performance  in  higher
dimensional space using PCA (and up to 50 PCs), but the algorithm never found more
than one lineage (data not shown). 
When looking  at  our  single-cell  data,  we  do  see  the  expression  of  T helper  defining
cytokines. However, instead of an exclusive expression of TH1 or TH2 markers, we notice
that cells express high levels of (all detected) T helper cytokines (IFN-γ, IL-4, IL-13) and
granzymes as well as other chemokines or they have much reduced (baseline) levels of
these genes. There is even a small positive correlation between IFN-γ and IL-13 (data not
shown).  This  kind of  coexpression of  exclusive  T helper  hallmark cytokines has been
noted on the population-level since the early days of human T cell research 208. Here we
also discovered that this holds true on the single-cell level. This effect becomes even more
pronounced when considering the restimulated population of cells.
Restimulating in vitro differentiated T cells with PMA and Ionomycin helped capture more
lowly expressed and relevant transcripts without impacting on cell viability, yet it did not
help us to distinguish T helper types. One recently published single-cell dataset of in vivo
differentiated but in vitro restimulated (with anti-CD3, anti-CD28 ABs) T cells from multiple
human tissues  found  similarly  significant  differences between stimulation  conditions  but
could not detect discrete or even clear but overlapping T helper types112. 
We wanted to ensure that the lack of distinct T helper subsets in our single-cell data was
not  caused by low sensitivity  or  other  issues,  such as batch effect  (removal)  and cell
culture methods. To that end, we decided to investigate the matter further with low-input
bulk sequencing. We can easily increase our SCRB-seq protocol's sensitivity by increasing
the number of cells per well during capture. This means that we will lose the single-cell
resolution,  but  we  gain  the  possibility  to  study  the  same  sample  with  many  different
methods and detect  lowly expressed transcripts  that  might  not  have been captured in
scRNA-seq. 
For  bulk  sequencing,  we  prepared  knockouts  of  two  of  the  primary  T  helper  master
regulators,  GATA3 and  TBX21,  and  additional  32  WT samples.  All  the  samples  were
expanded in a monoclonal fashion and should spontaneously differentiate into T helper
subsets (Fig.5.1 B and C).  The knockout samples of master transcription factors were
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included to skew cells towards specific T helper lineages. When normal GATA3 functioning
is perturbed, the T cells should spontaneously acquire the TH1 phenotype and vice versa
for  TBX21 and TH2209,210. We confirmed the T helper phenotypes of our KOs with ELISA
before proceeding with the sequencing. 
The  bulk  sequencing  results  reflected  our  previous  finding  on  a  single-cell  level.  The
majority of  variation in the data was caused by the PMA and Ionomycin restimulation.
Interestingly  there  was  a  lot  more  variation  within  all  the  WT clones  than  there  was
between  the  knockouts.  GATA3-/- showed  increased  IFN-γ and  TNF expression,  and
TBX21-/- had increased IL-4 and IL-13 expression. Although the trends in the expression of
these hallmark cytokines in the RNA-seq data and ELISA data agreed, there were still
some noticeable differences. On the protein level, the cytokine expression pattern is more
clear-cut. The TH2 specific cytokine expression is abolished in  GATA3-/-, and TH1 specific
cytokine expression is severely reduced in TBX21-/-. However, on the transcriptional level,
we can still detect residual levels of those cytokines. It is hard to discern whether these
differences are due to measurement sensitivities or post-transcriptional  regulation211.  In
line with the latter hypothesis, we also noticed similarly contrasting expression profiles in
flow cytometry data, which is also a protein-based assay.
Our expectation of using the KOs to guide our analysis by defining T helper subsets based
on their gene expression profile (GATA3-/- are TH1-like and TBX21-/- are TH2-like) was not
met. As already noted before, the WT samples showed more variation among each other
than the KO clones, and no clustering dictated by the genotype was noticeable in the PCA
plot.  Also,  clustering algorithms (Louvain,  k-means,  hierarchical  clustering) did  not  find
clusters in a way that would separate our two control genotypes from each other. 
The  master  regulators  do  not  seem to  govern  the  whole  T helper  cell  transcriptional
program instead, they only regulate a very limited number of transcripts, such as IL-4, IL-
5, IL-13, and IFN-γ. To pursue this further, we conducted a DE analysis between those two
genotypes. Since the samples do not separate from each other in the PCA, the difference
in their gene expression was also minor. Most of the upregulated genes in  GATA3-/- are
known IFN-γ targets. Even this slight difference all but vanished if we compared these two
genotypes in the resting state.  The sole DE transcript  was  CCL5,  a gene that  is also
known  to  be  induced  by  IFN-γ212–214.  Considering  that  GATA3 is  a  known  IFN-γ
repressor188,215,  it  is not surprising that  GATA3-/- samples had the highest expression of
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IFN-γ, even in the resting state as indicated by CCL5 upregulation. Taken together, these
results indicate that IFN-γ differential expression is the primary driver of variation between
GATA3-/- and TBX21-/-. 
One way to explain these results, which is also in line with other published data, is to use the
T  cell  plasticity  model,  where  already  differentiated  memory  T  helper  cells  undergo
additional  changes  (chromatin  remodeling  and  or  DNA  methylation)  in  response  to
environmental cues to switch between predefined cell types. Typically T helper cells are
considered to be stable due to epigenetic changes and histone acetylations. Additionally to
that, the master regulators should not only induce their TH type defining cytokines but also
suppress  the  characteristics  of  the  opposing  TH type208.  However,  over  the  last  three
decades, each of these regulatory checkpoints has been found to be bypassed both in vitro
and in vivo. TH1 cells have been shown to be capable of IL-4 production without losing IFN-γ
production, and some T cells co-produce IL-4 and IFN-γ102,216. All conventional memory T
helper  cell  types can change their  expression profile  under  specific  microenvironmental
conditions102–105. TH1 and TH2 cells have been both found to be co-expressing GATA3 and
TBX21217. Also, the epigenetic modifications of T helper cells are not as straightforward as
the cytokine expression profiles and do not follow the T helper cell type patterns218. So either
the  memory  T helper  cell  types  are  not  as  well  defined  as  previously  thought,  or  the
differences between those types are far more minor, or these phenotypes are much more
overlapping. 
Another way of interpreting the single-cell data in light of these contradictory findings has
been gaining support in recent years. The so-called polarized continuum or heterogeneous
continuum model does not separate memory T helper cells into distinct groups, rather these
cells can occupy any possible state between the known extremes (conventional T helper
types). In all of the published scRNA-seq datasets discussed in this work, we see that there
are  no  clear  and  distinct  clusters  of  T  helper  subsets.  Even  if  some  areas  of  these
heterogeneous  populations  express  higher  levels  of  hallmark  cytokines,  the  borders
between supposed T helper subsets are by no means clear. 
It is, of course, possible to run clustering algorithms on those continuous populations to try
to find subsets. Such analysis is, in fact, commonplace, but the resulting clusters might not
have anything to do with actual biology. This is how we end up with multiple TH1 subtypes or
“unknown”  clusters  of  T  helper  cells  that  do  not  seem  to  fall  into  any  conventional
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category112,113,115,195. 
All of the above speaks in favor of the continuum model, but there could be a few technical
considerations why we cannot distinguish between different  types of T helper cells on a
transcriptional  level.  By  definition,  T  cell  types  are  assigned  based  on  their  cytokine
expression profiles219, and in our datasets, we only saw different T helper cell types when
we limited  the  cell  type  assignment  to  a  handful  of  cytokines.  It  could  be  that  these
lineages specific cytokines are all the difference there is between the T helper cell types. 
Another possibility is that there is more differential expression between T helper cell types
but all of those transcripts are moderately or lowly expressed and not reliably picked up
with current scRNA-seq methods.  However, Heimberg et al. showed in their 2016 paper
that gene expression data is inherently low dimensional. That means that genes tend not
to  vary  in  their  expression individually,  but  instead,  they are  co-expressed together  in
modules, thus the lower dimensionality. The implication of this is that RNA-seq data should
be surprisingly robust to technical noise; for example, as few as 100 transcripts per cell
would suffice to distinguish between oligodendrocytes and neurons117. That is around 100
fold fewer features/genes than an average droplet-based sequencing platform manages or
1000 fold less than plate-based methods like SCRB-seq151. Unless differences between T
helper  cell  types are  exceedingly  small,  any  current  generation  single-cell  sequencing
platform should, therefore be able to find it.
Even though the low sensitivity is unlikely to be an issue,  considering our scRNA-seq
capabilities, we still performed a low-input bulk RNA sequencing on T helper cells. The
bulk nature of this experiment helped us validate our scRNA-seq findings and combine it
with additional read-outs for the same samples (ELISA). We did not find definite evidence
of  TH archetypes of  in  vitro  differentiated  CD4+ T cells  on  population-level  either.  The
increased sensitivity revealed what we already noticed in single-cell data: a continuum of
samples (or cells in scRNA-seq) that differ only slightly from each other. Even when we
could  validate  our  results  with  complementary  methods  such  as  ELISA and  assign  a
putative phenotype to our samples, we could not verify these findings in RNA-seq data
when considering the entire transcriptome. Only when we limited the dataset to a few key
cytokines were we finally able to tell our positive controls apart.
Taking  all  of  that  into  account,  it  seems  that  distinct  T  helper  types  might  be  more
accurately described as a continuum of cells with different active transcriptional programs
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rather than a set cell type. Interestingly we see a similar heterogeneous continuum of cells
in the T helper cell counterparts, the ILCs 88–90. Both fields have struggled to define the cell
types solely based on scRNA-seq data. Instead, there’s a growing number of studies that
try to model the response of individual cells as dictated by pathogens and environmental
cues they come in contact with91,196.  This would also make more biological sense as it
would not be very efficient to have a specific cell type for each occasion (pathogen), as
there is a potentially unlimited number of them. Instead, a “Jack-of-all-trades” could be a
more capable system. 
One final topic to consider is the difference between RNA and protein-level read-outs. We
have almost exclusively looked at transcriptomics data in this work, but the conventional
assays for T helper cell types have been performed on protein level. One issue that we
currently cannot reconcile is the fact that under the flow cytometry conditions, we see quite
clear differences between different skewing or KO conditions on a cellular level. There
could be as of yet unknown post-translational modifications that influence these read-outs.
While single-cell whole proteome studies are being developed, they are yet not available
for  the type of studies conducted here.  However,  partial  single-cell  proteomics studies
using  CyTOF  also  reveal  much  the  same  picture  of  continuous  heterogeneous
populations195,220–222. As a quick side note, all of the CyTOF data as well as scRNA-seq
data reviewed here always shows a clear distinction between CD4+ and CD8+ T cells. Also
naive T helper cells separate quite clearly in a non-overlapping manner from memory T
cells. The reason why CyTOF data resembles scRNA-seq data might be because of the
increased number of parameters measured in any given experiment. As long as the read-
outs are limited to only a few parameters, it is possible to distinguish between T helper cell
types.  Yet,  when  multi-parametric  read-outs  are  considered  in  their  entirety,  these
differences vanish.
T cell research has constantly undergone changes and revisions. The TH1-TH2 dichotomy
that lasted for almost 20 years was abandoned with the discovery of the third lineage,
TH17 cells. In light of the data presented here and recently published work, it might be time
to let go of the T helper cell archetypes, especially when all the assays are increasingly
more high-throughput and multi-parametric. It seems ill-advised to assign something so
complex  as  a  cell  type  solely  by  the  expression  of  a  few  genes.  Especially  when
considering that the said cell types have never shown clear distinction to begin with99. 
94
It is unlikely that this matter will be settled any time soon, but there seems to be more
acceptance that  T cell-extrinsic  factors  might  have more  to  do with  their  function and
properties  than intrinsic  factors  and debatable  subtypes115,196.  This  study has hopefully
shed  some  light  on  this  matter.  Of  course,  it  is  necessary  to  consider  this  project's
limitations, namely that we only worked with in vitro samples and differentiated the cells
under  non-polarizing  conditions.  Yet  our  results,  as  well  as  other  published  results113,
indicate that there would be few if any, significant differences between different T helper
phenotypes whether they are brought up under polarizing or non-polarizing conditions. 
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6  Summary
RNA sequencing, along with single-cell RNA sequencing, has been gaining popularity in the
last decade and a half. It has almost become a routine method, and numerous commercial
and non-commercial methods to perform transcriptomics analysis exist. Despite it being so
widespread,  setting  up  an  RNA  sequencing  platform,  especially  a  single-cell  RNA
sequencing platform, is not without its own pitfalls. Although much more straightforward to
implement, commercial solutions impose their own restrictions i.e., the choice of reagents,
need of microfluidic chips, and constrictions to the general experimental setup. On the other
hand, homemade protocols offer much more flexibility in regards to initial investments as
well as experimental design and the possibility to combine it with other instruments for more
in-depth analysis.
In this work, we showed the capabilities of our improved single-cell sequencing platform
– SCRB-seq,  in detecting transcriptional  changes in BLaER1 macrophages after LPS
stimulation.  We  could  further  show  that  our  modifications  to  the  original  protocol
substantially improved the sequencing results and that integrating different datasets (all
produced with the same protocol) was feasible and increased the statistical  power of
RNA-seq analysis.
The properties of SCRB-seq also allow it to be used for low-input bulk RNA sequencing
experiments. There are several benefits to such a setup. The main one is the reduced cost
achieved  by  drastically  reducing  the  hands-on  time  during  the  library  preparation,
multiplexing the samples (reducing reagent and material cost), and tag-based sequencing of
the  libraries.  The  resulting  digital  gene  expression  read-out  is  especially  beneficial  for
experiments with a large sample sizes, such as screens.
We used this low-input setup to characterize the PRR stimulation in BLaER1 macrophages
in a knockout-dependent manner. With three different stimulation conditions (LPS, dsDNA,
and unstimulated) and 13 different genotypes, we successfully prepared and sequenced
150 samples.  In  an unbiased fashion,  we could uncover the importance of  the chosen
factors  involved in  TLR4 and  cGAS-STING signaling.  Moreover,  we could  uncover  the
redundancy of  certain kinases in the NF-κB pathway (CHUCK  and  IKBKB),  and in the
interferon signaling pathway (IKBKE and TBK1), respectively.
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The main focus of this work was to sequence and analyze CD4+ T cells’ activation and
differentiation  and  find  time-dependent  regulators  of  cell  fate.  To  characterize  these
processes, we conducted two scRNA-seq experiments and one low-input bulk sequencing
experiment.  For both for single-cell  and bulk sequencing, we found that restimulation is
required to capture cytokine profiles characteristic for T helper cells. We were, however, not
successful  in detecting conventional  T helper subtypes on a single-cell  level,  neither  in
resting nor in restimulated populations. Instead, our data revealed that the T helper cells,
brought  up  under  non-polarizing  conditions,  exhibit  a  continuous  and  heterogeneous
population  of  cells,  where  the  main  drivers  of  variation  are  restimulation  and  the
differentiation time. This was in clear contrast to the results obtained by flow cytometric
analysis, in which distinct populations of T helper subtypes could be discerned.
In bulk sequencing data, we could confirm that the expression of hallmark cytokines ( IL-
4, IL-13, IFN-γ) was indeed dependent on T cell-fate master transcription factors GATA3
and TBX21. As such, we could reliably distinguish between T helper types on population-
level,  but  only when limiting our analysis to those cytokines. In fact,  when the whole
transcriptome  was  compared  in  an  unbiased  fashion,  deficiency  of  these  master
regulators had little to no impact and a meaningful  grouping into subtypes would not
have been possible. In fact, there was more variation between wild-type samples than
between the knockouts.
In all three datasets, we noticed a high expression of cytotoxic genes such as  GZMA,
GZMB,  GZMH,  and  GNLY,  as well  as an almost ubiquitous expression of  CSF2.  The
expression of these genes remained unaltered in different knockout conditions and was
only  dependent  on  differentiation  time.  This  would  be  an  interesting  area  for  further
investigation as these transcripts could possibly serve as additional markers for T helper
differentiation.
In summary, this study has shed some light into difficulties identifying T helper types in
complex  samples  using  scRNA-seq.  Two  of  the  main  problems:  overlapping  cytokine
production, and the continuous population of T cells do not seem to be caused by shallow
sequencing depth, but is instead appear to be an inherent property of T helper cells on a
single-cell level. In the future, combining transcriptomics assays with additional readouts
such as single-cell proteomics, epigenomics, and metabolomics could help to reconcile the
differences we see on single cell vs. population level. 
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